LIGHTPATH TECHNOLOGIES INC - Quarter Report: 2019 March (Form 10-Q)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
[X]
QUARTERLY REPORT
UNDER SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31,
2019
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
For the
transition period from ___________ to ____________
Commission file number 000-27548
LIGHTPATH TECHNOLOGIES, INC.
------------------------------------------------------------------------
(Exact name of registrant as specified in its
charter)
DELAWARE
|
86-0708398
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S.
Employer Identification
No.)
|
2603 Challenger Tech Ct. Suite 100
Orlando, Florida 32826
-----------------------------------------------------------
(Address of principal executive offices)
(ZIP Code)
(407) 382-4003
---------------------------------------------
(Registrant’s telephone number, including area
code)
N/A
----------------------------------------------------------------------------------------------------
(Former name, former address, and former fiscal year, if changed
since last report)
Securities registered pursuant to Section 12(b) of the
Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
None
|
None
|
None
|
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. YES [X] NO [ ]
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or such shorter period
that the registrant was required to submit such
files).
YES [ X ] NO [ ]
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,”
“accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large accelerated filer [ ]
|
Accelerated
filer [ ]
|
Non-accelerated filer [ X]
|
Smaller
reporting company [ X ]
|
|
Emerging
growth company [ ]
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act [
]
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). YES [ ] NO
[X]
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the
issuer’s classes of common stock, as of the latest
practicable date:
25,813,895 shares of common stock, Class A, $.01 par value,
outstanding as of May 6, 2019.
LIGHTPATH TECHNOLOGIES, INC.
Form 10-Q
Index
Item
|
|
Page
|
|
Cautionary
Note Concerning Forward-Looking
Statements
|
|
4
|
|
Financial Information
|
|
5
|
|
Financial Statements
|
|
5
|
|
|
Unaudited Condensed Consolidated Balance Sheets
|
|
5
|
|
Unaudited Condensed Consolidated Statements of Comprehensive Income
(Loss)
|
|
6
|
|
Unaudited Condensed Consolidated Statement of Stockholders’
Equity
|
|
7
|
|
Unaudited Condensed Consolidated Statements of Cash
Flows
|
|
8
|
|
Notes to Unaudited Condensed Consolidated Financial
Statements
|
|
9
|
Management’s Discussion and Analysis of Financial Condition
and Results of Operations
|
|
20
|
|
|
Overview
|
|
20
|
|
Results of Operations
|
|
21
|
|
Liquidity and Capital Resources
|
|
24
|
|
Contractual Obligations and Commitments
|
|
25
|
|
Off-Balance Sheet Arrangements
|
|
25
|
|
Critical Accounting Policies and Estimates
|
|
25
|
|
Non-GAAP Financial Measures
|
|
29
|
Controls and Procedures
|
|
31
|
|
|
|
|
|
Other Information
|
|
32
|
|
Legal Proceedings
|
|
32
|
|
Unregistered Sales of Equity Securities and Use of
Proceeds
|
|
32
|
|
Defaults Upon Senior Securities
|
|
32
|
|
Mine Safety Disclosures
|
|
32
|
|
Other Information
|
|
32
|
|
Exhibits
|
|
32
|
|
|
|
|
|
Signatures
|
|
36
|
CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS
Certain statements and information in this Quarterly Report on Form
10-Q for the quarter ended March 31, 2019 (the “Quarterly
Report”) may constitute “forward-looking
statements” within the meaning of Section 27A of the
Securities Act of 1933, as amended (the “Securities
Act”), Section 21E of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and the Private
Securities Litigation Reform Act of 1995. All statements, other
than statements of historical facts, which address activities,
events, or developments that we expect or anticipate will or may
occur in the future, including such things as future capital
expenditures, growth, product development, sales, business
strategy, and other similar matters are forward-looking statements.
In some cases, you can identify forward-looking statements by
terminology such as “may,” “will,”
“should,” “expect,” “plan,”
“anticipate,” “believe,”
“estimate,” “predict,”
“potential,” or “continue,” or other
comparable terminology. These forward-looking statements are based
largely on our current expectations and assumptions and are subject
to a number of risks and uncertainties, many of which are beyond
our control. These statements are subject to many risks,
uncertainties, and other important factors that could cause actual
future results to differ materially from those expressed in the
forward-looking statements. For a discussion of risks and
uncertainties that could cause actual results to differ materially
from those contained in our forward-looking statements, please
refer to Item 1A, Risk Factors, in our Annual Report on Form 10-K
for the year ended June 30, 2018. In light of these risks and
uncertainties, all of the forward-looking statements made herein
are qualified by these cautionary statements and there can be no
assurance that the actual results or developments anticipated by us
will be realized. We undertake no obligation to update or revise
any of the forward-looking statements contained
herein.
4
PART I
Financial Information
Item 1. Financial
Statements
LIGHTPATH TECHNOLOGIES, INC.
|
||
Condensed Consolidated Balance Sheets
|
||
(unaudited)
|
||
|
|
|
|
March
31,
|
June
30,
|
Assets
|
2019
|
2018
|
Current
assets:
|
|
|
Cash
and cash equivalents
|
$4,641,457
|
$5,508,620
|
Restricted
cash
|
-
|
1,000,000
|
Trade
accounts receivable, net of allowance of $27,145 and
$13,364
|
5,899,062
|
5,370,508
|
Inventories,
net
|
7,586,734
|
6,404,741
|
Other
receivables
|
3,789
|
46,574
|
Prepaid
expenses and other assets
|
934,068
|
1,058,610
|
Total
current assets
|
19,065,110
|
19,389,053
|
|
|
|
Property
and equipment, net
|
12,520,168
|
11,809,241
|
Intangible
assets, net
|
8,120,826
|
9,057,970
|
Goodwill
|
5,854,905
|
5,854,905
|
Deferred
tax assets, net
|
1,030,000
|
624,000
|
Other
assets
|
319,021
|
381,945
|
Total
assets
|
$46,910,030
|
$47,117,114
|
Liabilities and Stockholders’ Equity
|
|
|
Current
liabilities:
|
|
|
Accounts
payable
|
$2,424,960
|
$2,032,834
|
Accrued
liabilities
|
789,886
|
685,430
|
Accrued
payroll and benefits
|
1,194,182
|
1,228,120
|
Loans
payable, current portion
|
581,350
|
1,458,800
|
Capital
lease obligation, current portion
|
401,666
|
307,199
|
Total
current liabilities
|
5,392,044
|
5,712,383
|
|
|
|
Capital
lease obligation, less current portion
|
673,659
|
550,127
|
Deferred
rent
|
633,526
|
377,364
|
Loans
payable, less current portion
|
5,140,837
|
5,119,796
|
Total
liabilities
|
11,840,066
|
11,759,670
|
|
|
|
Commitments
and Contingencies
|
|
|
|
|
|
Stockholders’
equity:
|
|
|
Preferred
stock: Series D, $.01 par value, voting;
|
|
|
500,000
shares authorized; none issued and outstanding
|
—
|
—
|
Common
stock: Class A, $.01 par value, voting;
|
|
|
44,500,000
shares authorized; 25,813,895 and 25,764,544
|
|
|
shares
issued and outstanding
|
258,139
|
257,645
|
Additional
paid-in capital
|
230,226,315
|
229,874,823
|
Accumulated
other comprehensive income
|
752,675
|
473,508
|
Accumulated
deficit
|
(196,167,165)
|
(195,248,532)
|
Total
stockholders’ equity
|
35,069,964
|
35,357,444
|
Total
liabilities and stockholders’ equity
|
$46,910,030
|
$47,117,114
|
The accompanying notes are an integral part of these unaudited
condensed consolidated financial
statements.
5
LIGHTPATH TECHNOLOGIES, INC.
|
||||
Condensed Consolidated Statements of Comprehensive Income
(Loss)
|
||||
(unaudited)
|
||||
|
|
|
||
|
Three
Months Ended March 31,
|
Nine
Months Ended March 31,
|
||
|
2019
|
2018
|
2019
|
2018
|
Revenue,
net
|
$7,905,582
|
$8,503,628
|
$25,003,810
|
$24,437,094
|
Cost
of sales
|
4,799,913
|
5,211,602
|
15,313,825
|
14,344,015
|
Gross
margin
|
3,105,669
|
3,292,026
|
9,689,985
|
10,093,079
|
Operating
expenses:
|
|
|
|
|
Selling,
general and administrative
|
2,431,819
|
2,362,578
|
7,414,550
|
7,054,996
|
New
product development
|
505,636
|
384,380
|
1,494,412
|
1,178,849
|
Amortization
of intangibles
|
283,521
|
329,270
|
937,143
|
987,812
|
(Gain)
loss on disposal of property and equipment
|
(136,125)
|
—
|
(92,868)
|
3,315
|
Total
operating costs and expenses
|
3,084,851
|
3,076,228
|
9,753,237
|
9,224,972
|
Operating
income (loss)
|
20,818
|
215,798
|
(63,252)
|
868,107
|
Other
income (expense):
|
|
|
|
|
Interest
expense, net
|
(275,233)
|
342,796
|
(573,535)
|
(52,212)
|
Change
in fair value of warrant liability
|
—
|
—
|
—
|
(194,632)
|
Other
income (expense), net
|
64,267
|
484,531
|
(322,339)
|
927,383
|
Total
other income (expense), net
|
(210,966)
|
827,327
|
(895,874)
|
680,539
|
Income
(loss) before income taxes
|
(190,148)
|
1,043,125
|
(959,126)
|
1,548,646
|
Income
tax provision (benefit)
|
161,870
|
(183,154)
|
(40,493)
|
(318,678)
|
Net
income (loss)
|
$(352,018)
|
$1,226,279
|
$(918,633)
|
$1,867,324
|
Foreign
currency translation adjustment
|
53,327
|
77,477
|
279,167
|
200,886
|
Comprehensive
income (loss)
|
$(298,691)
|
$1,303,756
|
$(639,466)
|
$2,068,210
|
Earnings
(loss) per common share (basic)
|
$(0.01)
|
$0.05
|
$(0.04)
|
$0.08
|
Number
of shares used in per share calculation (basic)
|
25,810,681
|
25,546,512
|
25,788,286
|
24,763,458
|
Earnings
(loss) per common share (diluted)
|
$(0.01)
|
$0.04
|
$(0.04)
|
$0.07
|
Number
of shares used in per share calculation (diluted)
|
25,810,681
|
27,281,010
|
25,788,286
|
26,618,956
|
The accompanying
notes are an integral part of these unaudited condensed
consolidated financial statements.
6
LIGHTPATH TECHNOLOGIES, INC.
Condensed Consolidated Statements of Stockholders'
Equity
(unaudited)
|
|
|
|
Accumulated
|
|
|
|
Class A
|
|
Additional
|
Other
|
|
Total
|
|
Common Stock
|
|
Paid-in
|
Comphrehensive
|
Accumulated
|
Stockholders’
|
|
Shares
|
Amount
|
Capital
|
Income
|
Deficit
|
Equity
|
Balances at June 30, 2018
|
25,764,544
|
$257,645
|
$229,874,823
|
$473,508
|
$(195,248,532)
|
$35,357,444
|
Issuance
of common stock for:
|
|
|
|
|
|
|
Employee
Stock Purchase Plan
|
9,061
|
91
|
20,750
|
—
|
—
|
20,841
|
Stock-based
compensation on stock options & RSUs
|
—
|
—
|
93,910
|
—
|
—
|
93,910
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
173,047
|
—
|
173,047
|
Net
loss
|
—
|
—
|
—
|
—
|
(582,891)
|
(582,891)
|
Balances at September 30, 2018
|
25,773,605
|
$257,736
|
$229,989,483
|
$646,555
|
$(195,831,423)
|
$35,062,351
|
Issuance
of common stock for:
|
|
|
|
|
|
|
Exercise
of stock options & RSUs, net
|
15,667
|
157
|
4,104
|
—
|
—
|
4,261
|
Stock-based
compensation on stock options & RSUs
|
—
|
—
|
103,905
|
—
|
—
|
103,905
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
52,793
|
—
|
52,793
|
Net
income
|
—
|
—
|
—
|
—
|
16,276
|
16,276
|
Balances at December 31, 2018
|
25,789,272
|
$257,893
|
$230,097,492
|
$699,348
|
$(195,815,147)
|
$35,239,586
|
Issuance
of common stock for:
|
|
|
|
|
|
|
Exercise
of stock options, net
|
12,813
|
128
|
9,378
|
—
|
—
|
9,506
|
Employee
Stock Purchase Plan
|
11,810
|
118
|
20,963
|
—
|
—
|
21,081
|
Stock-based
compensation on stock options & RSUs
|
—
|
—
|
98,482
|
—
|
—
|
98,482
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
53,327
|
—
|
53,327
|
Net
loss
|
—
|
—
|
—
|
—
|
(352,018)
|
(352,018)
|
Balances at March 31, 2019
|
25,813,895
|
$258,139
|
$230,226,315
|
$752,675
|
$(196,167,165)
|
$35,069,964
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at June 30, 2017
|
24,215,733
|
$242,157
|
$225,492,252
|
$295,396
|
$(196,308,636)
|
$29,721,169
|
Issuance
of common stock for:
|
|
|
|
|
|
|
Exercise
of warrants
|
25,000
|
250
|
30,000
|
—
|
—
|
30,250
|
Employee
Stock Purchase Plan
|
7,093
|
71
|
19,009
|
—
|
—
|
19,080
|
Reclassification
of warrant liability upon exercise
|
—
|
—
|
34,500
|
—
|
—
|
34,500
|
Stock-based
compensation on stock options & RSUs
|
—
|
—
|
92,241
|
—
|
—
|
92,241
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
54,147
|
—
|
54,147
|
Net
income
|
—
|
—
|
—
|
—
|
217,695
|
217,695
|
Balances at September 30, 2017
|
24,247,826
|
$242,478
|
$225,668,002
|
$349,543
|
$(196,090,941)
|
$30,169,082
|
Exercise
of warrants
|
408,810
|
4,088
|
504,980
|
—
|
—
|
509,068
|
Exercise
of stock options
|
46,250
|
463
|
103,238
|
—
|
—
|
103,701
|
Reclassification
of warrant liability upon exercise
|
—
|
—
|
650,632
|
—
|
—
|
650,632
|
Stock-based
compensation on stock options & RSUs
|
—
|
—
|
377,367
|
—
|
—
|
377,367
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
69,262
|
—
|
69,262
|
Net
income
|
—
|
—
|
—
|
—
|
423,351
|
423,351
|
Balances at December 31, 2017
|
24,702,886
|
$247,029
|
$227,304,219
|
$418,805
|
$(195,667,590)
|
$32,302,463
|
Exercise
of warrants
|
—
|
—
|
(5,000)
|
—
|
—
|
(5,000)
|
Employee
Stock Purchase Plan
|
12,887
|
129
|
29,382
|
—
|
—
|
29,511
|
Exercise
of stock options
|
47,563
|
475
|
89,974
|
—
|
—
|
90,449
|
Settlement
of Sellers Note
|
967,208
|
9,672
|
2,237,392
|
—
|
—
|
2,247,064
|
Stock-based
compensation on stock options & RSUs
|
—
|
—
|
93,187
|
—
|
—
|
93,187
|
Foreign
currency translation adjustment
|
—
|
—
|
—
|
77,477
|
—
|
77,477
|
Net
income
|
—
|
—
|
—
|
—
|
1,226,278
|
1,226,278
|
Balances at March 31, 2018
|
25,730,544
|
$257,305
|
$229,749,154
|
$496,282
|
$(194,441,312)
|
$36,061,429
|
The accompanying
notes are an integral part of these unaudited condensed
consolidated financial statements.
7
LIGHTPATH TECHNOLOGIES, INC.
|
||
Condensed Consolidated Statements of Cash Flows
|
||
(unaudited)
|
||
|
|
|
|
Nine
Months Ended March 31,
|
|
|
2019
|
2018
|
Cash
flows from operating activities:
|
|
|
Net
(loss) income
|
$(918,633)
|
$1,867,324
|
Adjustments
to reconcile net (loss) income to net cash provided by operating
activities:
|
|
|
Depreciation
and amortization
|
2,540,963
|
2,492,003
|
Interest
from amortization of debt costs
|
112,618
|
13,704
|
(Gain)
loss on disposal of property and equipment
|
(92,868)
|
3,315
|
Stock-based
compensation on stock options & RSUs, net
|
296,297
|
279,397
|
Provision
for doubtful accounts receivable
|
(4,436)
|
(11,868)
|
Change
in fair value of warrant liability
|
—
|
194,632
|
Change
in fair value of Sellers Note
|
—
|
(396,163)
|
Deferred
rent amortization
|
(52,720)
|
(58,234)
|
Inventory
write-offs to reserve
|
3,193
|
134,052
|
Deferred
tax benefit
|
(406,000)
|
(205,884)
|
Changes
in operating assets and liabilities:
|
|
|
Trade
accounts receivable
|
(523,661)
|
312,026
|
Other
receivables
|
42,575
|
(29,018)
|
Inventories
|
(1,614,551)
|
(1,013,201)
|
Prepaid
expenses and other assets
|
181,200
|
(409,137)
|
Accounts
payable and accrued liabilities
|
461,970
|
(500,237)
|
Net
cash provided by operating activities
|
25,947
|
2,672,711
|
|
|
|
Cash
flows from investing activities:
|
|
|
Purchase
of property and equipment
|
(1,673,482)
|
(2,481,715)
|
Proceeds
from sale of equipment
|
316,750
|
—
|
Net
cash used in investing activities
|
(1,356,732)
|
(2,481,715)
|
|
|
|
Cash
flows from financing activities:
|
|
|
Proceeds
from exercise of stock options
|
13,767
|
194,150
|
Proceeds
from sale of common stock from Employee Stock Purchase
Plan
|
41,922
|
48,591
|
Loan
costs
|
(92,860)
|
(60,453)
|
Borrowings
on loan payable
|
5,813,500
|
2,942,583
|
Proceeds
from exercise of warrants, net of costs
|
—
|
534,318
|
Payments
on loan payable
|
(6,686,167)
|
(4,351,836)
|
Payments
on capital lease obligations
|
(244,210)
|
(196,790)
|
Net
cash used in financing activities
|
(1,154,048)
|
(889,437)
|
Effect
of exchange rate on cash and cash equivalents
|
617,670
|
(998,410)
|
Change
in cash and cash equivalents and restricted cash
|
(1,867,163)
|
(1,696,851)
|
Cash
and cash equivalents and restricted cash, beginning of
period
|
6,508,620
|
8,085,015
|
Cash
and cash equivalents and restricted cash, end of
period
|
$4,641,457
|
$6,388,164
|
|
|
|
Supplemental
disclosure of cash flow information:
|
|
|
Interest
paid in cash
|
$379,539
|
$417,550
|
Income
taxes paid
|
$297,599
|
$562,491
|
Supplemental
disclosure of non-cash investing & financing
activities:
|
|
|
Purchase
of equipment through capital lease arrangements
|
$462,209
|
$306,220
|
Reclassification
of warrant liability upon exercise
|
—
|
$685,132
|
Derecognition
of liability associated with stock option grants
|
—
|
$283,399
|
Conversion
of Sellers Note to Common Stock
|
—
|
$2,247,064
|
The accompanying
notes are an integral part of these unaudited condensed
consolidated financial statements.
8
LIGHTPATH TECHNOLOGIES, INC.
Notes to Unaudited Condensed Consolidated Financial
Statements
1.
Basis
of Presentation
References
in this document to “the Company,”
“LightPath,” “we,” “us,” or
“our” are intended to mean LightPath Technologies,
Inc., individually, or as the context requires, collectively with
its subsidiaries on a consolidated basis.
The
accompanying unaudited Condensed Consolidated Financial Statements
have been prepared in accordance with the requirements of Article 8
of Regulation S-X promulgated under the Exchange Act and,
therefore, do not include all information and footnotes necessary
for a fair presentation of financial position, results of
operations, and cash flows in conformity with accounting principles
generally accepted in the United States of America. These unaudited
Condensed Consolidated Financial Statements should be read in
conjunction with our Consolidated Financial Statements and related
notes, included in our Annual Report on Form 10-K for the fiscal
year ended June 30, 2018, filed with the Securities and Exchange
Commission (the “SEC”). Unless otherwise stated,
references to particular years or quarters refer to our fiscal
years ended June 30 and the associated quarters of those fiscal
years.
These
Condensed Consolidated Financial Statements are unaudited, but
include all adjustments, including normal recurring adjustments,
which, in the opinion of management, are necessary to present
fairly our financial position, results of operations and cash flows
for the interim periods presented. The Consolidated Balance Sheet
as of June 30, 2018 has been derived from the audited financial
statements at that date but does not include all of the information
and notes required by generally accepted accounting principles for
complete financial statements. Results of operations for interim
periods are not necessarily indicative of the results that may be
expected for the year as a whole. The unaudited Condensed
Consolidated Financial Statements include the accounts of the
Company and its wholly-owned subsidiaries. All significant
intercompany balances and transactions have been eliminated in
consolidation.
2.
Significant Accounting Policies
Our significant accounting policies are provided in Note 2,
Summary of
Significant Accounting Policies, in the Consolidated Financial Statements in our
Annual Report on Form 10-K for the fiscal year ended June 30,
2018.
Use of Estimates
Management makes estimates and assumptions during the preparation
of our unaudited Condensed Consolidated Financial Statements that
affect amounts reported in the unaudited Condensed Consolidated
Financial Statements and accompanying notes. Such estimates and
assumptions could change in the future as more information becomes
available, which, in turn, could impact the amounts reported and
disclosed herein.
Recently Adopted Accounting Standards
Revenue from Contracts with Customers – In May 2014, the Financial Accounting
Standards Board (“FASB”) issued Accounting Standards
Update (“ASU”) No. 2014-9, Revenue from Contracts with
Customers (“ASU
2014-9”). The standard, along with the amendments issued in
2016 and 2015, provides companies with a single model for use in
accounting for revenue arising from contracts with customers and
supersedes current revenue recognition guidance, including
industry-specific revenue guidance. The core principle of the model
is to recognize revenue when control of the goods or services
transfers to the customer, as opposed to recognizing revenue when
the risks and rewards transfer to the customer under the previous
revenue guidance. ASU 2014-9 is required to be adopted, using
either of two methods: (i) retrospective to each prior reporting
period presented with the option to elect certain practical
expedients as defined within ASU 2014-9; or (ii) retrospective with
the cumulative effect of initially applying ASU 2014-9 recognized
at the date of initial application and providing certain additional
disclosures. This standard, as amended, is effective for annual and
interim periods beginning after December 15, 2017 and permits
entities to early adopt for annual and interim reporting periods
beginning after December 15, 2016. We adopted this standard as of
July 1, 2018, using the modified retrospective transition method.
The impact on the Consolidated Financial Statements upon adoption
of this standard was immaterial. For additional information, see
Note 3, Revenue, to these unaudited Condensed Consolidated
Financial Statements.
Income Taxes – In October
2016, the FASB issued ASU 2016-16, Income Taxes
(Topic 740) (“ASU
2016-16”). ASU 2016-16 will require an entity to recognize
the income tax consequences of an intra-entity transfer of an
asset, other than inventory, when the transfer occurs. ASU 2016-16
is effective for fiscal years beginning after December 15, 2017,
and interim periods within those fiscal years. ASU 2016-16 was
effective for us beginning in the first quarter of fiscal 2019. We
adopted this standard effective July 1, 2018, and there was no
significant impact on the unaudited Condensed Consolidated
Financial Statements upon the adoption of this
standard.
9
Compensation – Stock
Compensation – In May 2017, the FASB issued ASU
2017-09, Compensation - Stock
Compensation (Topic 718): Scope
of Modification Accounting (“ASU 2017-09”). The new
guidance clarifies when a change to the terms or conditions of a
share-based payment award must be accounted for as a modification.
ASU 2017-09 is effective for fiscal years, and interim periods
within those annual periods, beginning after December 15, 2017. ASU
2017-09 was effective for us beginning in the first quarter of
fiscal 2019. We adopted this standard effective July 1, 2018, and
there was no impact on the unaudited Condensed Consolidated
Financial Statements upon the adoption of this
standard.
There have been no other material changes to our significant
accounting policies during the nine months ended March 31, 2019,
from those disclosed in our Annual Report on Form 10-K for the
fiscal year ended June 30, 2018.
Recent Accounting Standards Yet to be Adopted
Leases – In February
2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). This guidance
requires an entity to recognize lease liabilities and a
right-of-use asset for all leases on the balance sheet and to
disclose key information about the entity’s leasing
arrangements. ASU 2016-02 must be adopted using a modified
retrospective approach for all leases existing at, or entered into
after the date of initial adoption, with an option to elect to use
certain transition relief. ASU 2016-02 is effective for annual
reporting periods beginning after December 15, 2018, including
interim periods within that reporting period, with earlier adoption
permitted. Our current operating lease portfolio is primarily
comprised of real estate leases. Upon adoption of this standard, we
expect our Consolidated Balance Sheet to include a right-of-use
asset and liability related to substantially all operating lease
arrangements. ASU 2016-02 is effective for us beginning in the
first quarter of our fiscal year ending June 30,
2020.
3.
Revenue
On July 1, 2018, the Company adopted ASU 2014-9 using the modified
retrospective method, which required us to record a cumulative
effect adjustment, if any, at the date of adoption. The adoption
did not have a material impact on our unaudited Condensed
Consolidated Financial Statements and, as a result, no changes were
made to prior reporting periods presented.
Product Revenue
We are a manufacturer of optical components and higher-level
assemblies, including precision molded glass aspheric optics,
molded and diamond-turned infrared aspheric lenses, and other
optical materials used to produce products that manipulate light.
We design, develop, manufacture, and distribute optical components
and assemblies utilizing advanced optical manufacturing processes.
We also perform research and development for optical solutions for
a wide range of optics markets. Revenue is derived primarily from
the sale of optical components and assemblies.
Revenue Recognition
Revenue is generally recognized upon transfer of control of
promised products or services to customers in an amount that
reflects the consideration we expect to receive in exchange for
those products or services. We generally bear all costs, risk of
loss, or damage and retain title to the goods up to the point of
transfer of control of promised products to customers. Shipping and
handling costs are included in the cost of goods sold. We present
revenue net of sales taxes and any similar
assessments.
Customary payment terms are granted to customers, based on credit
evaluations. We currently do not have any contracts where revenue
is recognized, but the customer payment is contingent on a future
event. We record deferred revenue when cash payments are received
or due in advance of our performance. Deferred revenue was
immaterial as of June 30, 2018 and March 31, 2019.
Nature of Products
Revenue from the sale of optical components and
assemblies is recognized upon transfer of control to the customer.
The performance obligations for the sale of optical components and
assemblies are satisfied at a point in time. Product development
agreements are generally short term in nature, with revenue
recognized upon transfer of control of the agreed-upon deliverable.
We have organized our products in three groups: precision molded
optics (“PMO”), infrared, and specialty products.
Revenues from product development agreements are included in
specialty products. Our revenue by product group for the three and
nine months ended March 31, 2019 and 2018 was as
follows:
|
Three
Months Ended March 31,
|
Nine
Months EndedMarch 31,
|
||
|
2019
|
2018
|
2019
|
2018
|
PMO
|
$3,351,916
|
$3,603,670
|
$10,590,111
|
$10,144,516
|
Infrared
Products
|
3,833,969
|
4,149,026
|
12,524,741
|
11,987,377
|
Specialty
Products
|
719,697
|
750,932
|
1,888,958
|
2,305,201
|
Total
revenue
|
$7,905,582
|
$8,503,628
|
$25,003,810
|
$24,437,094
|
10
4.
Inventories
The
components of inventories include the following:
|
March
31,
2019
|
June
30,
2018
|
Raw
materials
|
$3,104,825
|
$2,309,454
|
Work
in process
|
2,588,073
|
2,506,891
|
Finished
goods
|
2,687,663
|
2,263,121
|
Allowance
for obsolescence
|
(793,827)
|
(674,725)
|
|
$7,586,734
|
$6,404,741
|
The
value of tooling in raw materials was approximately $1.9 million
and $1.6 million at March 31, 2019 and June 30, 2018,
respectively.
5.
Property and Equipment
Property
and equipment are summarized as follows:
|
Estimated
|
March
31,
|
June
30,
|
|
Lives
(Years)
|
2019
|
2018
|
|
|
|
|
|
|
|
|
Manufacturing
equipment
|
5 - 10
|
$17,688,302
|
$16,534,124
|
Computer
equipment and software
|
3 - 5
|
667,175
|
513,681
|
Furniture
and fixtures
|
5
|
288,474
|
199,872
|
Leasehold
improvements
|
5 - 7
|
1,989,263
|
1,350,482
|
Construction
in progress
|
|
858,611
|
954,317
|
Total
property and equipment
|
|
21,491,825
|
19,552,476
|
|
|
|
|
Less
accumulated depreciation and amortization
|
|
(8,971,657)
|
(7,743,235)
|
Total
property and equipment, net
|
|
$12,520,168
|
$11,809,241
|
11
6.
Goodwill and Intangible Assets
There were no changes in the net carrying value of goodwill during
the nine months ended March 31, 2019, and there have been no events
of changes in circumstances that indicate the carrying value of
goodwill may not be recoverable.
Identifiable intangible assets were comprised of:
|
Useful
|
March
31,
|
June
30,
|
|
Lives
(Years)
|
2019
|
2018
|
Customer
relationships
|
15
|
$3,590,000
|
$3,590,000
|
Backlog
|
2
|
366,000
|
366,000
|
Trade
secrets
|
8
|
3,272,000
|
3,272,000
|
Trademarks
|
8
|
3,814,000
|
3,814,000
|
Non-compete
agreement
|
3
|
27,000
|
27,000
|
Total
intangible assets
|
|
11,069,000
|
11,069,000
|
Less
accumulated amortization
|
|
(2,948,174)
|
(2,011,030)
|
Total
intangible assets, net
|
|
$8,120,826
|
$9,057,970
|
Future amortization of identifiable intangibles is as
follows:
Fiscal
year ending:
|
|
June
30, 2019 (remaining three months)
|
$283,520
|
June
30, 2020
|
1,129,342
|
June
30, 2021
|
1,125,083
|
June
30, 2022
|
1,125,083
|
June
30, 2023 and later
|
4,457,798
|
|
$8,120,826
|
7. Accounts Payable
The
accounts payable balance as of March 31, 2019 and June 30, 2018
both include approximately $82,000 of earned but unpaid Board of
Directors’ fees.
12
8. Income Taxes
A
summary of our total income tax expense and effective income tax
rate for the three and nine months ended March 31, 2019 and 2018 is
as follows:
|
Three
Months Ended March 31,
|
Nine
Months Ended March 31,
|
||
|
2019
|
2018
|
2019
|
2018
|
Income
(loss) before income taxes
|
$(190,148)
|
$1,043,125
|
$(959,126)
|
$1,548,646
|
Income
tax provision (benefit)
|
$161,870
|
$(183,154)
|
$(40,493)
|
$(318,678)
|
Effective
income tax rate
|
-85%
|
-18%
|
4%
|
-21%
|
The
difference between our effective tax rates in the periods presented
above and the federal statutory rate is due to the mix of taxable
income and losses generated in our various tax jurisdictions, which
include the United States (“U.S.”), the People’s
Republic of China, and the Republic of Latvia. For the three months
ended March 31, 2019, the provision for income taxes is primarily
attributable to tax expense on income generated in China. For the
nine months ended March 31, 2019, we recorded a net income tax
benefit, representing a tax benefit on losses in the U.S.
jurisdiction, offset by tax expense on income generated in China.
The income tax benefit for the three and nine months ended March
31, 2018 was primarily related to discrete income tax items related
to our non-U.S. operations. First, the statutory tax rate
applicable to one of our Chinese subsidiaries, LightPath Optical
Instrumentation (Zhenjiang) Co., Ltd. (“LPOIZ”), was
lowered from 25% to 15% in accordance with an incentive program for
technology companies. The rate change occurred during the three
months ended December 31, 2017, and applied to LPOIZ’s 2017
tax year, beginning on January 1, 2017. Accordingly, we recorded a
tax benefit during the nine months ended March 31, 2018 related to
this retroactive rate change. Second, the Republic of Latvia
enacted income tax reform effective January 1, 2018, which resulted
in a tax benefit from the reduction of the previously recorded net
deferred tax liability to zero during the three months ended March
31, 2018.
We
record net deferred tax assets to the extent we believe it is more
likely than not that some portion or all of these assets will be
realized. The ultimate realization of deferred tax assets is
dependent upon the generation of future taxable income during the
periods in which those temporary differences become deductible. We
consider the scheduled reversal of deferred tax liabilities,
projected future taxable income, and tax planning strategies in
making this assessment. As of March 31, 2019, and June 30, 2018, we
have provided for a valuation allowance against our net deferred
tax assets to reduce the net deferred tax assets to the amount we
estimate is more-likely-than-not to be realized. Our net deferred
tax asset consists primarily of U.S. net operating loss
(“NOL”) carryforward benefits, and federal and state
tax credits with indefinite carryover periods.
Tax Cuts and Jobs Act
In December 2017, Congress passed, and the President signed into
law, the Tax Cuts and Jobs Act (the “2017 Act”), which
changed existing U.S. tax law and included various provisions that
affect companies in the United States. Among other things, the 2017
Act: (i) changed U.S. corporate tax rates, (ii) generally reduced a
company’s ability to utilize accumulated net operating
losses, and (iii) required the calculation of a one-time transition
tax on certain foreign earnings and profits (“foreign
E&P”) that had not been previously
repatriated.
During the quarter ended December 31, 2018, we completed our
accounting of the income tax impact from the enactment of the 2017
Act and there were no material changes from the estimates reported
in our Annual Report on Form 10-K for the year ended June 30, 2018.
The 2017 Act provides for a one-time transition tax on our
post-1986 foreign E&P that have not been previously
repatriated. We determined that our foreign E&P was
approximately $9.9 million and we do not owe any one-time
transition tax due to the utilization of U.S. NOL carryforward
benefits against these earnings. We have also completed our
evaluation of the U.S. federal corporate income tax impacts of the
Global Intangible Low-Taxed Income and Foreign-Derived Intangible
Income provisions of the 2017 Act, and our tax expense includes the
impact of these provisions as a period cost in our effective tax
rate.
Income Tax Law of the People’s Republic of China
Our Chinese subsidiaries, LightPath Optical Instrumentation
(Shanghai) Co., Ltd. (“LPOI”) and LPOIZ, are governed
by the Income Tax Law of the People’s Republic of China. As
of March 31, 2019, LPOI and LPOIZ were subject to statutory income
tax rates of 25% and 15%, respectively.
We currently intend to permanently invest earnings generated from
our foreign Chinese operations and, therefore, have not previously
provided for future Chinese withholding taxes on such related
earnings. However, if in the future we change such intention, the
Company would provide for and pay additional foreign taxes, if any,
at that time.
Law of Corporate Income Tax of Latvia
Our Latvian subsidiary, ISP Optics Latvia, SIA (“ISP
Latvia”), is governed by the Law of Corporate Income Tax of
Latvia. As of December 31, 2017, ISP Latvia was subject to a
statutory income tax rate of 15%. Effective January 1, 2018, the
Republic of Latvia enacted tax reform with the following key
provisions: (i) corporations are no longer subject to income tax,
but are instead subject to a distribution tax on distributed
profits (or deemed distributions, as defined) and (ii) the tax rate
was changed to 20%; however, distribution amounts are first divided
by 0.8 to arrive at the taxable amount of profit, resulting in an
effective tax rate of 25%. As a transitional measure, distributions
made from earnings prior to January 1, 2018, distributed prior to
December 31, 2019, are not subject to tax. As such, any
distributions of profits from ISP Latvia to ISP Optics Corporation
(“ISP”), its U.S. parent company, will be from earnings
prior to January 1, 2018 and, therefore, will not be subject to
tax. We currently do not intend to distribute any current earnings
generated after January 1, 2018. If, in the future, we change such
intention, we will accrue distribution taxes, if any, as profits
are generated.
13
9. Stock-Based Compensation
Our directors, officers, and key employees were granted stock-based
compensation through our Amended and Restated Omnibus Incentive
Plan, as amended (the “Omnibus Plan”), through October
2018 and after that date, the 2018 Stock and Incentive Compensation
Plan (the “SICP”). The awards include incentive stock
options, non-qualified stock options, and restricted stock unit
(“RSU”) awards. The stock-based compensation expense is
based primarily on the fair value of the award as of the grant
date, and is recognized as an expense over the requisite service
period.
The following table shows total stock-based compensation expense
for the nine months ended March 31, 2019 and 2018 included in the
accompanying unaudited Condensed Consolidated Statements of
Comprehensive Income:
|
Nine
Months EndedMarch 31,
|
|
|
2019
|
2018
|
|
|
|
Stock
options
|
$32,963
|
$29,450
|
RSUs
|
263,334
|
249,947
|
Total
|
$296,297
|
$279,397
|
|
|
|
The amounts above were included in:
|
|
|
Selling,
general & administrative
|
$294,859
|
$274,005
|
Cost
of sales
|
1,620
|
4,388
|
New
product development
|
(182)
|
1,004
|
|
$296,297
|
$279,397
|
We also adopted the LightPath Technologies, Inc. Employee Stock
Purchase Plan (the “2014 ESPP”). The 2014 ESPP permits
employees to purchase Class A common stock through payroll
deductions, subject to certain limitations. A discount of $3,856
and $4,879 for the nine months ended March 31, 2019 and 2018,
respectively, is included in the selling, general and
administrative expense in the accompanying unaudited Condensed
Consolidated Statements of Comprehensive Income, which represents
the value of the 10% discount given to the employees purchasing
stock under the 2014 ESPP.
Grant Date Fair Values and Underlying Assumptions; Contractual
Terms
We estimate the fair value of each stock option as of the date of
grant, using the Black-Scholes-Merton pricing model. The fair value
of 2014 ESPP shares is the amount of the discount the employee
obtains at the date of the purchase transaction.
Most stock options granted vest ratably over two to four years and
are generally exercisable for ten years. The assumed forfeiture
rates used in calculating the fair value of RSU grants was 0%, and
the assumed forfeiture rates used in calculating the fair value of
options for performance and service conditions were 20% for each of
the nine months ended March 31, 2019 and 2018. The volatility rate
and expected term are based on seven-year historical trends in
Class A common stock closing prices and actual forfeitures. The
interest rate used is the U.S. Treasury interest rate for constant
maturities.
For stock options granted under the Omnibus Plan or SICP, as
applicable, in the nine-month periods ended March 31, 2019 and
2018, we estimated the fair value of each stock option as of the
date of grant using the following assumptions:
|
Nine Months Ended March 31,
|
||
|
2019
|
|
2018
|
Weighted-average expected volatility
|
56%-69%
|
|
63% - 75%
|
Dividend yields
|
0%
|
|
0%
|
Weighted-average risk-free interest rate
|
2.65%-3.00%
|
|
1.28% - 1.80%
|
Weighted-average expected term, in years
|
2.53
|
|
7.25
|
14
Information Regarding Current Share-Based Compensation
Awards
A summary of the activity for share-based compensation awards in
the nine months ended March 31, 2019 is presented
below:
|
|
Stock
Options
|
|
Stock
Units (RSUs)
|
|
|
|
Weighted-
|
Weighted-
|
|
Weighted-
|
|
|
Average
|
Average
|
|
Average
|
|
|
Exercise
|
Remaining
|
|
Remaining
|
|
Shares
|
Price
|
Contract
|
Shares
|
Contract
|
June 30, 2018
|
1,005,129
|
$1.77
|
6.3
|
1,649,353
|
0.9
|
|
|
|
|
|
|
Granted
|
13,058
|
$2.10
|
9.6
|
229,509
|
2.6
|
Exercised
|
(17,610)
|
$1.08
|
—
|
(14,336)
|
—
|
Cancelled/Forfeited
|
(20,652)
|
$1.17
|
—
|
—
|
—
|
March 31, 2019
|
979,925
|
$1.80
|
5.7
|
1,864,526
|
0.9
|
|
|
|
|
|
|
Awards
exercisable/
|
|
|
|
|
|
vested
as of
|
|
|
|
|
|
March 31, 2019
|
864,980
|
$1.70
|
5.4
|
1,464,382
|
—
|
|
|
|
|
|
|
Awards
unexercisable/
|
|
|
|
|
|
unvested
as of
|
|
|
|
|
|
March 31, 2019
|
114,945
|
$2.55
|
8.0
|
400,144
|
0.9
|
|
979,925
|
|
|
1,864,526
|
|
RSU awards vest immediately or from two to four years from the
grant date.
As of March 31, 2019, there was approximately $589,000 of total
unrecognized compensation cost related to non-vested share-based
compensation arrangements (including share options and RSUs)
granted. We expect to recognize the compensation cost as
follows:
|
Stock
|
|
|
|
Options
|
RSUs
|
Total
|
Three
months ending June 30, 2019
|
3,498
|
62,032
|
65,530
|
|
|
|
|
Year
ending June 30, 2020
|
8,926
|
289,944
|
298,870
|
|
|
|
|
Year
ending June 30, 2021
|
5,939
|
169,978
|
175,917
|
|
|
|
|
Year
ending June 30, 2022
|
2,021
|
46,654
|
48,675
|
|
$20,384
|
$568,608
|
$588,992
|
15
10.
Earnings (Loss) Per Share
Basic earnings per share is computed by dividing net income or loss
by the weighted-average number of shares of Class A common stock
outstanding, during each period presented. Diluted earnings per
share is computed similarly to basic earnings per share, except
that it reflects the potential dilution that could occur if
dilutive securities or other obligations to issue shares of Class A
common stock were exercised or converted into shares of Class A
common stock. The computations for basic and diluted earnings per
share of Class A common stock are presented in the following
table:
|
Three
Months Ended March 31,
|
Nine
Months Ended March 31,
|
||
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
Net
income (loss)
|
$(352,018)
|
$1,226,279
|
$(918,633)
|
$1,867,324
|
|
|
|
|
|
Weighted-average
common shares outstanding:
|
|
|
|
|
Basic number of shares
|
25,810,681
|
25,546,512
|
25,788,286
|
24,763,458
|
|
|
|
|
|
Effect
of dilutive securities:
|
|
|
|
|
Options
to purchase common stock
|
-
|
295,055
|
-
|
355,858
|
RSUs
|
-
|
1,439,443
|
-
|
1,381,190
|
Common
stock warrants
|
-
|
-
|
-
|
118,450
|
Diluted number of shares
|
25,810,681
|
27,281,010
|
25,788,286
|
26,618,956
|
|
|
|
|
|
Earnings (loss) per common share:
|
|
|
|
|
Basic
|
$(0.01)
|
$0.05
|
$(0.04)
|
$0.08
|
Diluted
|
$(0.01)
|
$0.04
|
$(0.04)
|
$0.07
|
The following potential weighted-average dilutive shares were not
included in the computation of diluted earnings per share of Class
A common stock, as their effects would be
anti-dilutive:
|
Three
Months Ended March 31,
|
Nine
Months Ended March 31,
|
||
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
Options
to purchase common stock
|
985,842
|
748,326
|
999,612
|
732,350
|
RSUs
|
1,864,526
|
209,911
|
1,755,893
|
208,138
|
Common
stock warrants
|
-
|
-
|
-
|
108,924
|
|
2,850,368
|
958,237
|
2,755,505
|
1,049,412
|
16
11.
Lease Commitments
We lease various facilities under non-cancelable operating leases,
expiring through 2022. Our leased facilities are located in
Orlando, Florida; Irvington, New York; Riga, Latvia; Shanghai,
China; and Zhenjiang, China. Rent expense totaled approximately
$817,000 and $779,000 during the nine months ended March 31, 2019
and 2018, respectively.
We currently have obligations under five capital lease agreements,
entered into during fiscal years 2016, 2017, 2018, and 2019, with
terms ranging from three to five years. The leases are for computer
and manufacturing equipment, which are included as part of property
and equipment. Assets under capital lease include approximately
$1.9 million in manufacturing equipment, with accumulated
amortization of approximately $822,000 as of March 31, 2019.
Amortization related to capital lease assets is included in
depreciation and amortization expense.
The approximate future minimum lease payments under capital and
operating leases at March 31, 2019 were as follows:
|
Capital
Leases
|
Operating
Leases
|
Fiscal year ending:
|
|
|
June
30, 2019 (three months remaining)
|
$119,903
|
$252,000
|
June
30, 2020
|
456,731
|
921,000
|
June
30, 2021
|
382,086
|
678,000
|
June
30, 2022
|
205,916
|
557,000
|
June
30, 2023
|
33,294
|
101,000
|
Total
minimum payments
|
1,197,930
|
$2,509,000
|
Less
imputed interest
|
(122,605)
|
|
Present
value of minimum lease payments included in capital lease
obligations
|
1,075,325
|
|
Less
current portion
|
(401,666)
|
|
Non-current
portion
|
$673,659
|
|
12.
Loans Payable
Avidbank Loan
Until February 26, 2019, loans payable consisted of the Term II
Loan (as defined below) payable to Avidbank Corporate Finance, a
division of Avidbank (“Avidbank”), pursuant to the
Second Amended and Restated Loan and Security Agreement (the
“LSA”) entered into on December 21, 2016, as amended by
the First Amendment to the LSA dated December 20, 2017 (the
“First Amendment”), the Second Amendment to the LSA
dated January 16, 2018 (the “Second Amendment”), the
Third Amendment to the LSA dated May 11, 2018 (the “Third
Amendment”), the Fourth Amendment to the LSA dated September
7, 2018 (the “Fourth Amendment”), and the Fifth
Amendment to the LSA dated October 30, 2018 (the “Fifth
Amendment,” and together with the LSA, First Amendment, the
Second Amendment, the Third Amendment, and the Fourth Amendment,
the “Amended LSA”). The First Amendment and Third
Amendment are discussed in detail in Item 8 under the heading
“Notes to the Consolidated Financial Statements – Note
18, Loans
Payable, in our latest Annual
Report on Form 10-K for the year ended June 30, 2018. The Second
Amendment, Fourth Amendment, and Fifth Amendment are discussed
below. The Amended LSA also provided for a working capital
revolving line of credit (the “Revolving
Line”).
Pursuant to the Amended LSA, Avidbank agreed to, in its discretion,
make loan advances under the Revolving Line to us up to a maximum
aggregate principal amount outstanding not to exceed the lesser of
(i) One Million Dollars ($1,000,000), or (ii) eighty percent (80%)
(the “Maximum Advance Rate”) of the aggregate balance
of our eligible accounts receivable, as determined by Avidbank in
accordance with the Amended LSA. Amounts borrowed under the
Revolving Line could be repaid and re-borrowed at any time prior to
the Revolving Maturity Date (as defined below), at which time all
amounts were immediately due and payable. There were no borrowings
under the Revolving Line during the nine months ended March 31,
2019. As of February 26, 2019, the date on which we terminated the
Amended LSA, there was no outstanding balance under the Revolving
Line.
Our obligations under the Amended LSA were collateralized by a
first priority security interest (subject to permitted liens) in
cash, U.S. inventory, accounts receivable and equipment. In
addition, our wholly-owned subsidiary, Geltech, Inc., guaranteed
our obligations under the Amended LSA.
The Amended LSA contained customary covenants, including, but not
limited to: (i) limitations on the disposition of property; (ii)
limitations on changing our business or permitting a change in
control; (iii) limitations on additional indebtedness or
encumbrances; (iv) restrictions on distributions; (v) limitations
on certain investments; and (vi) limitations on the amount of cash
held in financial institutions in Latvia. Additionally, the Amended
LSA required us to maintain a fixed charge coverage ratio (as
defined in the Amended LSA) of at least 1.15 to 1.00 and an asset
coverage ratio (as defined in the Amended LSA) of at least 1.50 to
1.00.
On January 16, 2018, we entered into the Second Amendment, which
established a new loan in the original principal amount of
$7,294,000 (the “Term II Loan”), the proceeds of which
were used to pay in full the previously outstanding acquisition
term loan, and a portion of a note payable to the sellers of ISP
(the “Sellers Note”). Contemporaneous with this
transaction, the Sellers Note was satisfied in full with the
issuance of 967,208 shares of our Class A common stock, with the
remaining balance paid in cash. The Term II Loan was for a
five-year term, and bore interest at a per annum rate equal to two
percent (2.0%) above the Prime Rate; provided, however, that at no
time would the applicable rate be less than five-and-one-half
percent (5.50%) per annum.
17
On September 7, 2018, we entered into the Fourth Amendment.
Pursuant to the Fourth Amendment, Avidbank granted us a waiver of
default arising prior to the Fourth Amendment from our failure to
comply with the fixed charge coverage ratio covenant measured on
June 30, 2018. Based on the waiver, we were no longer in default on
the Term II Loan or the Revolving Line. The Fourth Amendment also
provided for the restriction of $1 million of the Company’s
cash, which would be released upon two consecutive quarters of
compliance with the fixed charge coverage ratio covenant, and so
long as no event of default has occurred that is continuing on that
date. The Fourth Amendment also provided that during the
restrictive period, the calculation of the fixed charge coverage
ratio would be determined as if the outstanding principal amount of
the Term II Loan is $1 million less than the actual outstanding
principal amount of the Term II Loan.
On October 30, 2018, we entered into the Fifth Amendment, which
amended the definition of “Adjusted EBITDA” to allow
for the addback of certain one-time expenses for purposes of
determining the fixed charge coverage ratio and compliance with the
related covenant. The Fifth Amendment also extended the maturity
date of the Revolving Line from December 21, 2018 to March 21,
2019. As discussed in more detail below, on February 26, 2019, we
entered into the Loan Agreement (as defined below) with BankUnited,
N.A. (“BankUnited”), and used the proceeds from the
BankUnited Term Loan (as defined below) to pay in full, all
outstanding amounts owed pursuant to the Term II Loan. Accordingly,
as of March 31, 2019, there was no outstanding balance under the
Term II Loan.
BankUnited Loan
On February 26, 2019, we entered into a Loan Agreement (the
“Loan Agreement”) with BankUnited for (i) a
revolving line of credit up to maximum amount of $2,000,000 (the
“BankUnited Revolving Line”), (ii) a term loan in the
amount of up to $5,813,500 (“BankUnited Term Loan”),
and (iii) a non-revolving guidance line of credit up to a maximum
amount of $10,000,000 (the “Guidance Line” and,
together with the BankUnited Revolving Line and BankUnited Term
Loan, the “BankUnited Loans”). Each of the BankUnited
Loans is evidenced by a promissory note in favor of BankUnited (the
“BankUnited Notes”).
On May
6, 2019, we entered into that certain First Amendment to Loan
Agreement, effective February 26, 2019, with BankUnited (the
"Amendment" and, together with the Loan Agreement, the "Amended
Loan Agreement"). The Amendment amended the definition of the
fixed charge coverage ratio to more accurately reflect the parties'
understandings at the time the Loan Agreement was
executed.
BankUnited Revolving Line
Pursuant to the Amended Loan Agreement, BankUnited will make loan
advances under the BankUnited Revolving Line to us up to a maximum
aggregate principal amount outstanding not to exceed $2,000,000,
which proceeds will be used for working capital and general
corporate purposes. Amounts borrowed under the BankUnited Revolving
Line may be repaid and re-borrowed at any time prior to February
26, 2022, at which time all amounts will be immediately due and
payable. The advances under the BankUnited Revolving Line
bear interest, on the outstanding daily balance, at a per annum
rate equal to 2.75% above the 30-day LIBOR. Interest payments
are due and payable, in arrears, on the first day of each month.
BankUnited Term Loan
Pursuant to the Amended Loan Agreement, BankUnited advanced us
$5,813,500 to satisfy in full the amounts owed to Avidbank,
including the Term II Loan, and to pay the fees and expenses
incurred in connection with closing of the BankUnited Loans. The
BankUnited Term Loan is for a 5-year term, but co-terminus with the
BankUnited Revolving Line. The BankUnited Term Loan bears interest
at a per annum rate equal to 2.75% above the 30-day LIBOR. Equal
monthly principal payments of $48,445.83, plus accrued interest,
are due and payable, in arrears, on the first day of each month
during the term. Upon maturity, all principal and interest shall be
immediately due and payable. As of March 31, 2019, the applicable
interest rate was 5.24%.
Guidance Line
Pursuant to the Amended Loan Agreement, BankUnited, in its sole
discretion, may make loan advances to us under the Guidance Line up
to a maximum aggregate principal amount outstanding not to exceed
$10,000,000, which proceeds will be used for capital expenditures
and approved business acquisitions. Such advances must be in
minimum amounts of $1,000,000 for acquisitions and $500,000 for
capital expenditures, and will be limited to 80% of cost or as
otherwise determined by BankUnited. Amounts borrowed under the
Guidance Line may not re-borrowed. The advances under the Guidance
Line bear interest, on the outstanding daily balance, at a per
annum rate equal to 2.75% above the 30-day LIBOR. Interest
payments are due and payable, in arrears, on the first day of each
month. On each anniversary of the Amended Loan Agreement, monthly
principal payments become payable, amortized based on a ten-year
term.
Security and Guarantees
Our obligations under the Amended Loan Agreement are collateralized
by a first priority security interest (subject to permitted liens)
in all of our assets and the assets of our U.S. subsidiaries,
GelTech, Inc. (“GelTech”) and ISP, pursuant to a
Security Agreement granted by GelTech, ISP, and us in favor of
BankUnited. Our equity interests in, and the assets of, our foreign
subsidiaries are excluded from the security interest. In
addition, all of our subsidiaries have guaranteed our obligations
under the Amended Loan Agreement and related documents, pursuant to
Guaranty Agreements executed by us and our subsidiaries in favor of
BankUnited.
18
General Terms
The Amended Loan Agreement contains customary covenants, including,
but not limited to: (i) limitations on the disposition of property;
(ii) limitations on changing our business or permitting a change in
control; (iii) limitations on additional indebtedness or
encumbrances; (iv) restrictions on distributions; and (v)
limitations on certain investments. The Amended Loan Agreement also
contains certain financial covenants, including obligations to
maintain a fixed charge coverage ratio of 1.25 to 1.00 and a total
leverage ratio of 4.00 to 1.00. As of March 31, 2019, we are in compliance
with all required covenants.
We may prepay any or all of the Loans in whole or in part at any
time, without penalty or premium. Late payments are subject to a
late fee equal to five percent (5%) of the unpaid amount. Amounts
outstanding during an event of default accrue interest at a rate of
five percent (5%) above the 30-day LIBOR applicable
immediately prior to the occurrence of the event of default.
The Amended Loan Agreement contains other customary
provisions with respect to events of default, expense
reimbursement, and confidentiality.
Financing costs incurred were recorded as a discount on debt and
will be amortized over the term. Amortization of approximately
$113,000 and $13,700 is included in interest expense for the nine
months ended March 31, 2019 and 2018, respectively. For the three
and nine months ended March 31, 2019, this includes approximately
$94,000 of previously unamortized financing costs related to the
Term II Loan, which were expensed as of February 26, 2019 when this
note was paid in full.
Future maturities of loans payable are as follows:
|
BankUnited
Term Loan
|
Unamortized
Debt Costs
|
Total
|
Fiscal year ending:
|
|
|
|
June
30, 2019 (three months remaining)
|
$145,340
|
$(4,566)
|
$140,774
|
June
30, 2020
|
581,350
|
$(18,263)
|
563,087
|
June
30, 2021
|
581,350
|
$(18,263)
|
563,087
|
June
30, 2022
|
581,350
|
$(18,263)
|
563,087
|
June
30, 2023
|
581,350
|
$(18,263)
|
563,087
|
June
30, 2024
|
3,342,760
|
$(13,695)
|
3,329,065
|
Total
payments
|
$5,813,500
|
$(91,313)
|
$5,722,187
|
Less
current portion
|
|
|
(581,350)
|
Non-current
portion
|
|
|
$5,140,837
|
13.
Foreign
Operations
Assets and liabilities denominated in non-U.S. currencies are
translated at rates of exchange prevailing on the balance sheet
date, and revenues and expenses are translated at average rates of
exchange for the period. During the nine months ended March 31,
2019 and 2018, we recognized a loss of approximately $323,000 and a
gain of approximately $855,000 on foreign currency transactions,
respectively, included in the unaudited Condensed Consolidated
Statements of Comprehensive Income (Loss) in the line item entitled
“Other income (expense), net.” Gains or losses on the
translation of the financial statements of a non-U.S. operation,
where the functional currency is other than the U.S. dollar, are
reflected as a separate component of equity, which was a gain of
approximately $279,000 and $201,000 for the nine months ended March
31, 2019 and 2018, respectively.
Our
cash and cash equivalents totaled $4.6 million at March 31, 2019.
Of this amount, approximately 65% was held by our foreign
subsidiaries in China and Latvia. These foreign funds were
generated in China and Latvia as a result of foreign earnings. With
respect to the funds generated by our foreign subsidiaries in
China, the retained earnings in China must equal at least 150% of
the registered capital before any funds can be repatriated. As of
March 31, 2019, we have retained earnings in China of approximately
$3.3 million and we need to have $11.3 million before repatriation
will be allowed.
Assets
and net assets in foreign countries are as follows:
|
China
|
Latvia
|
|||||
|
March
31,
2019
|
|
June
30,
2018
|
|
March
31,
2019
|
|
June
30,
2018
|
Assets
|
$16.4 million
|
|
$14.7 million
|
|
$7.9 million
|
|
$6.4 million
|
Net assets
|
$14.0 million
|
|
$12.6 million
|
|
$7.2 million
|
|
$5.9 million
|
14.
Restructuring Costs
In July 2018, we announced the relocation and consolidation of
ISP’s New York facility (the “Irvington
Facility”) into our existing facilities in Orlando, Florida
and Riga, Latvia. We record charges for restructuring and other
exit activities related to the closure or relocation of business
activities at fair value, when incurred. Such charges include
termination benefits, contract termination costs, and costs to
consolidate facilities or relocate employees. For the nine months
ended March 31, 2019, we recorded approximately $394,000 in
expenses related to the relocation of the Irvington Facility. These
charges were mostly incurred during the three months ended December
31, 2018, and are included as a component of the “Selling,
general and administrative” expenses line item in our
unaudited Condensed Consolidated Statement of Comprehensive Income
(Loss). We estimate that we will incur an additional $250,000 in
expenses through June 30, 2019 related to this facility relocation.
We expect the relocation to be substantially completed by that
date. As of that date, we will have a remaining lease obligation of
up to $433,000, which will be accrued once we have fully vacated
the facility.
19
Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of
Operations
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations is designed to provide a reader of the financial
statements with a narrative report on our financial condition,
results of operations, and liquidity. This discussion and analysis
should be read in conjunction with the attached unaudited Condensed
Consolidated Financial Statements and notes thereto and our Annual
Report on Form 10-K for the year ended June 30, 2018, including the
audited Consolidated Financial Statements and notes thereto. The
following discussion contains forward-looking statements that
involve risks and uncertainties, such as statements of our plans,
objectives, expectations, and intentions. Our actual results could
differ materially from those discussed in the forward-looking
statements. Please also see the cautionary language at the
beginning of this Quarterly Report regarding forward-looking
statements.
The discussions of our results as presented in this Quarterly
Report include use of the non-GAAP term “gross margin,”
as well as other non-GAAP measures discussed in more detail under
the heading “Non-GAAP Financial Measures.” Gross margin
is determined by deducting the cost of sales from operating
revenue. Cost of sales includes manufacturing direct and indirect
labor, materials, services, fixed costs for rent, utilities and
depreciation, and variable overhead. Gross margin should not be
considered an alternative to operating income or net income, which
are determined in accordance with GAAP. We believe that gross
margin, although a non-GAAP financial measure, is useful and
meaningful to investors as a basis for making investment decisions.
It provides investors with information that demonstrates our cost
structure and provides funds for our total costs and expenses. We
use gross margin in measuring the performance of our business and
have historically analyzed and reported gross margin information
publicly. Other companies may calculate gross margin in a different
manner.
Introduction
We were incorporated in Delaware in 1992 as the successor to
LightPath Technologies Limited Partnership, a New Mexico limited
partnership, formed in 1989, and its predecessor, Integrated Solar
Technologies Corporation, a New Mexico corporation, formed in
1985.
We are in the business of manufacturing optical components and
higher level assemblies, including precision molded glass aspheric
optics, molded and diamond turned infrared aspheric lenses and
other optical materials used to produce products that manipulate
light. All the products we produce enable lasers and imaging
devices to function more effectively.
In November 2005, we formed LPOI, a wholly-owned subsidiary, located in
Jiading, People’s Republic of China. LPOI provides sales and
support functions. In December 2013, we formed LPOIZ, a
wholly-owned subsidiary located in the New City district, of the
Jiangsu province, of the People’s Republic of China.
LPOIZ’s 39,000 square foot manufacturing facility (the
“Zhenjiang Facility”) serves as our primary
manufacturing facility in China and provides a lower cost structure
for production of larger volumes of optical components and
assemblies.
In December 2016, we acquired ISP and its wholly-owned subsidiary,
ISP Latvia. ISP is a vertically integrated manufacturer offering a
full range of infrared products from custom infrared optical
elements to catalog and high-performance lens assemblies.
Historically, ISP’s Irvington Facility functioned as its
global headquarters for operations, while also providing
manufacturing capabilities, optical coatings, and optical and
mechanical design, assembly, and testing. In July 2018, we
announced plans to relocate this manufacturing facility to our
existing facilities in Orlando, Florida and Riga, Latvia. We expect
the relocation to occur in phases through the end of fiscal 2019.
ISP Latvia’s manufacturing facility is located in Riga,
Latvia (the “Riga Facility”). It is a manufacturer of
high-precision optics and offers a full range of infrared products,
including catalog and custom infrared optics. For additional
information, please refer to our Annual Report on Form 10-K for the
year ended June 30, 2018.
Product Groups and Markets:
Beginning in fiscal 2019, we reorganized our business into three
product groups: PMO (as defined below), specialty products, and
infrared products.
Our precision molded optics (the “PMO”) product group
consists of precision molded optics with varying applications and
includes our high volume PMOs and low volume PMOs. Our specialty
product group is comprised of value-added products, such as optical
subsystems, assemblies, and collimators, and non-recurring
engineering (“NRE”) products, consisting of those
products we develop pursuant to product development agreements that
we enter into with customers. Typically, customers approach us and
request that we develop new products or applications for our
existing products to fit their particular needs or specifications.
The timing and extent of any such product development is outside of
our control.
Our infrared product group is comprised of both molded and turned
infrared lenses and assemblies, and includes all of the products
offered by ISP. Near the end of fiscal 2018, we announced
comprehensive production capabilities and global availability for a
new line of infrared lenses made of a chalcogenide compound. We
developed this compound and grow it internally to produce Black
Diamond glass, which has been trademarked, and is marketed as BD6.
Currently, the majority of our infrared products are
germanium-based, which is subject to market pricing and
availability. BD6 offers a lower-cost alternative to germanium,
which we expect will benefit the cost structure of some of our
current infrared products, and allow us to expand our product
offerings in response to the markets’ increasing requirement
for low-cost infrared optics applications.
20
We have also aligned our marketing efforts by industry. We
currently serve the following major markets: industrial,
commercial, defense, medical, telecommunications, and
catalogs/distributors. Customers in each of these markets may
select the best optical technologies that suit their needs from our
entire suite of products, availing us to cross-selling
opportunities, particularly where we can leverage our knowledge
base of technical requirements against our expanding design
library. Within our product groups, we have various applications
that serve our major markets. For example, sales of our infrared
products are primarily to customers in the industrial market that
use thermal imaging technology. However, our infrared products can
also be used for gas sensing devices, spectrometers, night vision
systems, automotive driver systems, thermal weapon gun sights, and
infrared counter measure systems, among others.
Within the larger overall markets, which are estimated to be in the
multi-billions of dollars, we believe there is a market of
approximately $1.7 billion for our current products and
capabilities. We continue to believe our products will provide
significant growth opportunities over the next several years and,
therefore, we will continue to target specific applications in each
of these major markets. In addition to these major markets, a large
percentage of our revenues are derived from sales to unaffiliated
companies that purchase our products to fulfill their
customers’ orders, as well as unaffiliated companies that
offer our products for sale in their catalogs. Our strategy is to
leverage our technology, know-how, established low-cost
manufacturing capability and partnerships to grow our
business.
Results of Operations
Fiscal Third Quarter: Three months ended March 31, 2019, compared
to three months ended March 31, 2018
Revenues:
Revenue for the third quarter of fiscal 2019 was approximately $7.9
million, a decrease of approximately $598,000, or 7%, as compared
to the same period of the prior fiscal year. Revenue generated by
PMO products was approximately $3.4 million for the third quarter
of fiscal 2019, as compared to $3.6 million in the same period of
fiscal 2018, a decrease of approximately $252,000, or 7%. Although
sales of PMO products to customers in the telecommunications and
industrial markets increased by approximately $452,000 and
$113,000, respectively, these increases were offset by decreases in
sales to customers across our other markets. Revenue generated by
infrared products was approximately $3.8 million in the third
quarter of fiscal 2019, a decrease of approximately $315,000, or
8%, compared to approximately $4.1 million in the same period of
fiscal 2018. The decrease was primarily due to lower custom
business sales to customers in the industrial market. Revenue
generated by specialty products, which includes revenue for NRE
projects, was approximately $720,000 in the third quarter of fiscal
2019, a decrease of approximately $31,000, or 4%, as compared to
approximately $751,000 in the same period of fiscal 2018. This
decrease is primarily due to lower sales to customers in the
defense and medical markets, partially offset by increases in sales
to customers in the industrial market, as well as an increase in
catalog and distribution sales.
Cost of Sales and Gross Margin:
Gross margin in the third quarter of fiscal 2019 was approximately
$3.1 million, a decrease of 6%, as compared to approximately $3.3
million in the same quarter of the prior fiscal year. Gross margin
as a percentage of revenue remained at 39% for the third quarter of
fiscal 2019, compared to the same period of the prior fiscal year.
Total cost of sales was approximately $4.8 million for the third
quarter of fiscal 2019, a decrease of approximately 8%, compared to
$5.2 million for the same period of the prior fiscal year. The
decrease is driven by lower sales, offset by other cost increases,
including higher duties and freight charges resulting from newly
effective tariffs, and elevated costs including labor costs,
manufacturing inefficiencies, and increased overhead expenses
associated with the relocation of our Irvington Facility. Although
we expect to have higher costs for the remainder of fiscal 2019, we
expect costs and operating performance to improve after the
relocation of the Irvington Facility is completed during the fourth
quarter of fiscal 2019.
Selling, General and Administrative:
Selling, general and administrative (“SG&A”) costs
for the third quarter of fiscal 2019 were approximately $2.4
million, an increase of approximately 3%, as compared to
approximately $2.4 million in the same quarter of the prior fiscal
year. SG&A for the third quarter of fiscal 2019 included
approximately $103,000 of non-recurring expenses related to the
relocation of the Irvington Facility to our existing facilities in
Orlando, Florida, and Riga, Latvia. We expect SG&A costs will
continue to be elevated for the remainder of fiscal 2019, as we
continue to incur expenses related to this facility
relocation. We expect the
relocation to conclude during the fourth quarter of fiscal 2019,
and on a long-term basis, we expect the consolidation of our
manufacturing facilities to reduce our operating and overhead
costs.
New Product Development:
New product development costs were approximately $506,000 in the
third quarter of fiscal 2019, an increase of approximately
$121,000, or 32%, as compared to the same period of the prior
fiscal year. This increase was primarily due to increased wages
related to additional engineering employees to support the demand
for development. We anticipate that these expenses will remain at
current levels for the remainder of fiscal 2019.
21
Other Income (Expense):
In the third quarter of fiscal 2019, interest expense was
approximately $275,000, compared to net interest income of
approximately $343,000 in the same period of the prior fiscal year.
The difference in interest expense and income is due to discrete
items that occurred in each period. Interest expense for the three
months ended March 31, 2019 includes non-recurring costs associated
with the Term II Loan upon refinancing, including the write-off of
previously unamortized debt costs. For the three months ended March
31, 2018, net interest income included a gain of approximately
$467,000 associated with the satisfaction of the Sellers Note, in
full, and the reversal of the related fair value adjustment
liability. We expect interest expense to be lower during the
remainder of fiscal 2019 due to more favorable terms associated
with the new BankUnited Term Loan.
Other income, net, was approximately $64,000 in the third quarter
of fiscal 2019, compared to approximately $485,000 in the third
quarter of fiscal 2018, primarily resulting from foreign exchange
gains and losses. We execute all foreign sales from our Orlando and
New York facilities and inter-company transactions in United States
dollars, partially mitigating the impact of foreign currency
fluctuations. Assets and liabilities denominated in non-United
States currencies, primarily the Chinese Yuan and Euro, are
translated at rates of exchange prevailing on the balance sheet
date, and revenues and expenses are translated at average rates of
exchange for the year. During
the third quarter of fiscal 2019, we incurred a gain on foreign
currency translation of approximately $65,000, compared to $446,000
for the same period of the prior fiscal year.
Income Taxes:
During the third quarter of fiscal 2019, we recorded income tax
expense of approximately $162,000, compared to an income tax
benefit of approximately $183,000 for the same period of the prior
fiscal year. The income tax
expense for the third quarter of fiscal 2019 is primarily
attributable to income taxes on the income generated in China. The
income tax benefit for the third quarter of fiscal 2018 was
primarily related to tax reform enacted in the Republic of Latvia,
which was effective January 1, 2018. Accordingly, we recorded an
income tax benefit during the third quarter of fiscal 2018, due to
the reduction of the previously recorded net deferred tax liability
to zero. Please refer to Note 8, Income
Taxes, in the unaudited
Condensed Consolidated Financial Statements in this Quarterly
Report on Form 10-Q for additional information.
Net Income:
Net loss for the third quarter of fiscal 2019 was approximately
$352,000, or $0.01 basic and diluted loss per share, compared to
the third quarter of fiscal 2018, in which we reported net income
of approximately $1.2 million, or $0.05 basic and $0.04 diluted
earnings per share, respectively. The decrease in net income for
the third quarter of fiscal 2019, as compared to the third quarter
of fiscal 2018, is attributable to the following, which are
primarily non-operating items: (i) a decrease in operating income
of $195,000, due to additional expenses related to the relocation
of the Irvington Facility and an increase in new product
development costs, (ii) an unfavorable difference in interest
expense of $618,000, due to the transactions described above, (iii)
a decrease in foreign exchange gains of approximately $380,000, and
(iv) a $345,000 decrease in the income tax benefit.
Weighted-average shares of common stock outstanding were 25,810,681
basic and diluted, in the third quarter of fiscal 2019, compared to
basic and diluted of 25,546,512 and 27,281,010, respectively, in
the third quarter of fiscal 2018. The increase in the basic
weighted-average shares of common stock outstanding was due to
shares of Class A common stock issued under the 2014 ESPP, and upon
the exercises of stock options and RSUs.
22
Fiscal First Nine Months: Nine months ended March 31, 2019,
compared to nine months ended March 31, 2018
Revenues:
Revenue for the first nine months of fiscal 2019 was approximately
$25.0 million, an increase of approximately $567,000, or 2%, as
compared to the same period of the prior fiscal year. Revenue
generated by PMO products was approximately $10.6 million for the
first nine months of fiscal 2019, as compared to $10.1 million in
the same period of fiscal 2018, an increase of approximately
$446,000, or 4%. The increase is primarily due to a $1.4 million
increase in sales to customers in the telecommunications market,
partially offset by decreases in sales to customers in the medical
and commercial markets. Revenue generated by infrared products was
approximately $12.5 million in the first nine months of fiscal
2019, an increase of approximately $537,000, or 4%, compared to
approximately $12.0 million in the same period of fiscal 2018.
Industrial applications, firefighting cameras, and other public
safety applications continue to be the primary drivers of the
increased demand for infrared products. Revenue generated by our
specialty products was approximately $1.9 million in the first nine
months of fiscal 2019, a decrease of approximately $416,000, or
18%, compared to approximately $2.3 million in the same period of
fiscal 2018. This decrease is partially due to the timing of NRE
projects, as well as a decrease in sales of specialty products to
customers in the commercial, industrial, and defense markets,
partially offset by increased sales to medical
customers.
Cost of Sales and Gross Margin:
Gross margin in the first nine months of fiscal 2019 was
approximately $9.7 million, a decrease of 4%, as compared to
approximately $10.1 million in same period of the prior fiscal
year. Gross margin as a percentage of revenue was 39% for the first
nine months of fiscal 2019, compared to 41% in the same period of
the prior fiscal year. Total cost of sales was approximately $15.3
million for the first nine months of fiscal 2019, an increase of
approximately $970,000, compared to $14.3 million for the same
period of the prior fiscal year. The increase in cost of sales, and
associated decrease in gross margin as a percentage of revenue, is
primarily the result of a shift in mix within the infrared product
group, coupled with other cost increases such as higher duties and
freight charges resulting from newly effective tariffs, and
elevated costs associated with the relocation of the Irvington
Facility. With respect to the infrared sales mix, a higher
percentage of sales was derived from contract sales and a smaller
percentage of sales was derived from custom products for the first
nine months of fiscal 2019, as compared to the same period of the
prior fiscal year. While margins have historically been lower on
contract sales, we began to see some benefit from our margin
improvement efforts in the most recent quarter as we began shipping
against a new contract. With respect to material costs, the
standard material for our infrared products continues to be
germanium, which has inherent pricing volatility. As we convert
many of these products to our BD6 material, we expect our infrared
margins to improve over time. While sales of infrared products made
with this material have nearly doubled in the first nine months of
fiscal 2019, as compared to the same period of the prior fiscal
year, this still represents a small portion of our infrared revenue
and, therefore, has not yet had a significant impact on our gross
margin. Although we expect to have higher costs associated with the
relocation of the Irvington Facility for the remainder of fiscal
2019, we expect costs to improve after the relocation of the
Irvington Facility is completed during the fourth quarter of fiscal
2019.
Selling, General and Administrative:
SG&A costs for the first nine months of fiscal 2019 were
approximately $7.4 million, an increase of approximately 5%, as
compared to approximately $7.1 million in the same quarter of the
prior fiscal year. SG&A for the first nine months of fiscal
2019 included approximately $394,000 of non-recurring expenses
related to the relocation of the Irvington Facility to our existing
facilities in Orlando, Florida, and Riga, Latvia. We expect
SG&A costs to continue to be elevated for the remainder of
fiscal 2019, due to this facility relocation. We expect the relocation to conclude during the
fourth quarter of fiscal 2019, and on a long-term basis, we expect
the consolidation of our manufacturing facilities to reduce our
operating and overhead costs.
New Product Development:
New product development costs were approximately $1.5 million in
the first nine months of fiscal 2019, an increase of approximately
$316,000, or 27%, as compared to the same period of the prior
fiscal year. This increase was primarily due to increased wages for
additional engineering employees to support the demand for product
development. We anticipate that these expenses will remain at
current levels for the remainder of fiscal 2019.
Other Income (Expense):
In the first nine months of fiscal 2019, interest expense was
approximately $574,000, compared to approximately $52,000 in the
same period of the prior fiscal year. In the first nine months of
fiscal 2019, interest expense was impacted by the write-off of debt
costs associated with the termination of the Term II Loan, which
was refinanced with the BankUnited Term Loan, both of which
occurred on February 26, 2019. In the first nine months of fiscal
2018, net interest expense included a gain of approximately
$467,000 associated with the satisfaction of the Sellers Note, in
full, and the reversal of the related fair value adjustment
liability. We expect interest expense to be lower during the
remainder of fiscal 2019, due to more favorable terms associated
with the BankUnited Term Loan.
In the first nine months of fiscal 2018, we recognized non-cash
expense of approximately $194,000 related to the change in the fair
value of the warrants issued in connection with our June 2012
private placement. The June 2012 warrants expired on December 11,
2017; therefore, there was no remaining warrant liability as of
that date. Accordingly, we did not recognize any income or expense
in the first nine months of fiscal 2019 related to these
warrants.
Other expense, net, was approximately $322,000 in the first nine
months of fiscal 2019, compared to other income, net, of
approximately $927,000 in the same period of the prior fiscal year,
primarily resulting from foreign exchange gains and losses. We
execute all foreign sales from our Orlando and New York facilities
and inter-company transactions in United States dollars, partially
mitigating the impact of foreign currency fluctuations. Assets and
liabilities denominated in non-United States currencies, primarily
the Chinese Yuan and Euro, are translated at rates of exchange
prevailing on the balance sheet date, and revenues and expenses are
translated at average rates of exchange for the year. During the
first nine months of fiscal 2019, we incurred a loss on foreign
currency translation of approximately $323,000, compared to a gain
of $855,000 for the same period of the prior fiscal
year.
23
Income Taxes:
During the first nine months of fiscal 2019, we recorded an income
tax benefit of approximately $40,000, compared to an income tax
benefit of approximately $319,000 for the same period of the prior
fiscal year. The decrease in
our income tax benefit was primarily attributable to the mix of
taxable income and losses generated in our various tax
jurisdictions. For the first nine months of fiscal 2019, the net
income tax benefit represents a tax benefit on losses in the U.S.,
offset by tax expense on income generated in China. For the first
nine months of fiscal 2018, the net income tax benefit is primarily
related to an adjustment for a retroactive statutory tax rate
change for one of our Chinese subsidiaries, LPOIZ. In addition,
effective January 1, 2018, the Republic of Latvia enacted tax
reform, which resulted in a tax benefit, due to the reduction of
the previously recorded net deferred tax liability to zero during
the first nine months of fiscal 2018. Please refer to Note
8, Income
Taxes, in the unaudited
Condensed Consolidated Financial Statements in this Quarterly
Report on Form 10-Q for additional information.
Net Income (Loss):
Net loss for the first nine months of fiscal 2019 was approximately
$919,000, or $0.04 basic and diluted loss per share, compared to
the first nine months of fiscal 2018, in which we reported net
income of approximately $1.9 million, or $0.08 basic and $0.07
diluted earnings per share, respectively. The decrease in net
income for the first nine months of fiscal 2019, as compared to the
first nine months of fiscal 2018, is primarily attributable to the
following: (i) a decrease in gross margin of approximately
$403,000, (ii) an additional $394,000 in SG&A expenses related
to the relocation of the Irvington Facility, (iii) an increase in
new product development costs of approximately $316,000, (iv) an
increase in interest expense of $521,000, due to the transactions
described above, (v) an approximately $1.2 million unfavorable
difference in foreign exchange gains and losses, and (vi) a
decrease in income tax benefits of $278,000. These decreases were
offset by the absence of $194,000 in expenses related to the change
in fair value of the warrant liability.
Weighted-average shares of common stock outstanding were
25,788,286, for both basic and
diluted, in the first nine months of fiscal 2019, compared to basic
and diluted shares of 24,763,458 and 26,618,956, respectively, in
the first nine months of fiscal 2018. The increase in the basic
weighted-average common stock shares was primarily due to the
967,208 shares of Class A common stock issued during the third
quarter of fiscal 2018 in conjunction with the satisfaction of the
Sellers Note, and, to a lesser extent, shares of Class A common
stock issued under the 2014 ESPP, and upon the exercises of stock
options and RSUs.
Liquidity and Capital Resources
At March 31, 2019, we had working capital of approximately $13.7
million and total cash and cash equivalents of approximately $4.6
million, of which approximately $3 million of cash and cash
equivalents were held by our foreign subsidiaries.
Cash and cash equivalents held by our foreign subsidiaries were
generated in China and Latvia as a result of foreign earnings.
Before any funds can be repatriated from China, the retained
earnings in China must equal at least 150% of the registered
capital. As of March 31, 2019, we had retained earnings of $3.3
million and we must have $11.3 million before repatriation will be
allowed. Currently, we intend to permanently invest earnings from
our foreign Chinese operations; therefore, we have not previously
provided for future Chinese withholding taxes on the related
earnings. However, if, in the future, we change such intention, we
would provide for and pay additional foreign taxes, if any, at that
time.
Loans payable as of March 31, 2019 consist of the BankUnited Term
Loan pursuant to the Amended Loan Agreement. The Amended Loan
Agreement also provides for the BankUnited Revolving Line. As of
March 31, 2019, the outstanding balance on the BankUnited Term Loan
was approximately $5.8 million, and we had no borrowings
outstanding on the BankUnited Revolving Line. The Amended Loan
Agreement includes certain customary covenants. We were in compliance with all covenants as
of March 31, 2019. For
additional information, see Note 12, Loans
Payable, to the unaudited
Condensed Consolidated Financial Statements in this Quarterly
Report on Form 10-Q.
We believe that we have adequate financial resources to sustain our
current operations in the coming year. We have established
milestones that will be tracked to ensure that as funds are
expended, we are achieving results before additional funds are
committed. We anticipate sales growth in future years, primarily
from infrared products. We structured our sales team to enhance our
incremental organic growth position for our core aspheric lens
business, prime our operations for the anticipated high growth of
our new infrared products, and allow for the integration of
strategic acquisitions. We are also seeing a substantial increase
in revenue-generating opportunities and broader market applications
as a result of our investments in technologies that decreased our
lens production costs and expanded our production
capacity.
We generally rely on cash from operations and equity and debt
offerings, to the extent available, to satisfy our liquidity needs
and to maintain our ability to repay the BankUnited Term Loan.
There are a number of factors that could result in the need to
raise additional funds, including a decline in revenue or a lack of
anticipated sales growth, increased material costs, increased labor
costs, planned production efficiency improvements not being
realized, increases in property, casualty, benefit and liability
insurance premiums, and increases in other discretionary spending,
particularly sales and marketing related. We will also continue
efforts to keep costs under control as we seek renewed sales
growth. Our efforts continue to be directed toward improving cash
flow and profitability. If our efforts are not successful, we will
need to raise additional capital. Should capital not be available
to us at reasonable terms, other actions may become necessary in
addition to cost control measures and continued efforts to increase
sales. These actions may include exploring strategic options for
the sale of the Company, the sale of certain product lines, the
creation of joint ventures or strategic alliances under which we
will pursue business opportunities, the creation of licensing
arrangements with respect to our technology, or other
alternatives.
24
Cash Flows – Financings:
Net cash used in financing activities was approximately $1.2
million in the first nine months of fiscal 2019, compared to
approximately $890,000 used in the same period of the prior fiscal
year. Cash used in financing activities for the first nine months
of fiscal 2019 reflects approximately $1.2 million in principal
payments on our loans and capital leases, net, offset by
approximately $56,000 in proceeds from the exercise of stock
options and from the sale of Class A common stock under the 2014
ESPP. Cash used in financing activities for the first nine months
of fiscal 2018 reflected approximately $1.7 million in principal
payments on our loans and capital leases, net, offset by
approximately $777,000 in proceeds from the exercise of our June
2012 warrants, proceeds from the exercise of stock options, and
proceeds from the sale of Class A common stock under the 2014
ESPP.
Cash Flows – Operating and Investing:
Net cash provided by operations was approximately $26,000 for the
first nine months of fiscal 2019, compared to cash provided by
operations of approximately $2.7 million for the same period of the
prior fiscal year. The decrease in cash flow from operations is
primarily due to the decrease in net income for the first nine
months of fiscal 2019, as compared to the same period of the prior
fiscal year. In order to
improve cash flow from operations, we need to continue to focus on
sales growth and margin improvements, while managing selling,
administrative, and new product development
expenditures.
During the first nine months of fiscal 2019, we expended
approximately $1.7 million in investments in capital equipment,
compared to approximately $2.5 million in the same period of the
prior fiscal year. The majority of our capital expenditures during
the first nine months of fiscal 2019 were for the purchase of
equipment to enhance our lens coating capabilities and capacity, to
allow minimal disruption during the process of relocating our
Irvington Facility, as well as to strategically expand our
production capabilities in other areas. Capital expenditures for
the first nine months of fiscal 2018 were related the purchase of
equipment used to enhance or expand our production capacity and
capabilities, as well as the costs for the expansion and
improvements to LPOIZ’s Zhenjiang facility. Overall, we
anticipate that the level of capital expenditures during fiscal
2019 will be lower than in fiscal 2018, however, the total amount
expended will depend on opportunities and
circumstances.
Contractual Obligations and Commitments
As of March 31, 2019, our principal commitments consisted of
obligations under operating and capital leases, and debt
agreements. No material changes occurred during the first nine
months of fiscal 2019 in our contractual cash obligations to repay
debt or to make payments under operating and capital leases, or in
our contingent liabilities as disclosed in our Annual Report on
Form 10-K for the year ended June 30, 2018.
Off-Balance Sheet Arrangements
We do not engage in any activities involving variable interest
entities or off-balance sheet arrangements.
Critical Accounting Policies and Estimates
Other than the policy changes disclosed in Note 2,
Significant
Accounting Policies, to the
unaudited Condensed Consolidated Financial Statements in Item 1,
Part I of this Quarterly Report, if any, there have been no
material changes to our critical accounting policies and estimates
during the nine months ended March 31, 2019 from those disclosed in
Item 7. Management’s Discussion and Analysis of Financial
Condition and Results of Operations, of our Annual Report on Form
10-K for the year ended June 30, 2018.
Recent Accounting Pronouncements
See Note 2, Significant Accounting
Policies, to the unaudited
Condensed Consolidated Financial Statements in Item 1 of Part I of
this Quarterly Report for a description of recent accounting
pronouncements and accounting changes.
25
How We Operate
We have continuing sales of two basic types: occasional sales via
ad-hoc purchase orders of mostly standard product configurations
(our “turns” business) and the more challenging and
potentially more rewarding business of customer product
development. In this latter type of business, we work with
customers to help them determine optical specifications and even
create certain optical designs for them, including complex
multi-component designs that we call “engineered
assemblies.” This is followed by “sampling” small
numbers of the product for the customers’ test and
evaluation. Thereafter, should a customer conclude that our
specification or design is the best solution to their product need;
we negotiate and “win” a contract (sometimes called a
“design win”) – whether of a “blanket
purchase order” type or a supply agreement. The strategy is
to create an annuity revenue stream that makes the best use of our
production capacity, as compared to the turns business, which is
unpredictable and uneven. This annuity revenue stream can also
generate low-cost, high-volume type orders. A key business
objective is to convert as much of our business to the design win
and annuity model as is possible. We face several challenges in
doing so:
●
Maintaining
an optical design and new product sampling capability, including a
high-quality and responsive optical design engineering
staff;
●
The
fact that as our customers take products of this nature into higher
volume, commercial production (for example, in the case of molded
optics, this may be volumes over one million pieces per year) they
begin to work seriously to reduce costs – which often leads
them to turn to larger or overseas producers, even if sacrificing
quality; and
●
Our
small business mass means that we can only offer a moderate amount
of total productive capacity before we reach financial constraints
imposed by the need to make additional capital expenditures –
in other words, because of our limited cash resources and cash
flow, we may not be able to service every opportunity that presents
itself in our markets without arranging for such additional capital
expenditures.
Despite these challenges to winning more “annuity”
business, we nevertheless believe we can be successful in procuring
this business because of our unique capabilities in optical design
engineering that we make available on the merchant market, a market
that we believe is underserved in this area of service offering.
Additionally, we believe that we offer value to some customers as a
source of supply in the United States should they be unwilling to
commit their entire source of supply of a critical component to
foreign merchant production sources.
Our Key Performance Indicators:
Usually on a weekly basis, management reviews a number of
performance indicators, both qualitative and quantitative. These
indicators change from time to time as the opportunities and
challenges in the business change. These indicators are used to
determine tactical operating actions and changes. We believe that
our non-financial production indicators, such as those noted, are
proprietary information.
Financial indicators that are considered key and reviewed regularly
are as follows:
●
sales
backlog;
●
revenue
dollars and units by product group; and
●
other
key indicators.
These indicators are also used to determine tactical operating
actions and changes and are discussed in more detail
below.
26
Sales Backlog
Sales growth has been and continues to be our best indicator of
success. Our best view into the efficacy of our sales efforts is in
our “order book.” Our order book equates to sales
“backlog.” It has a quantitative and a qualitative
aspect: quantitatively, our backlog’s prospective dollar
value and qualitatively, what percent of the backlog is scheduled
by the customer for date-certain delivery. We define our
“12-month backlog” as that which is requested by the
customer for delivery within one year and which is reasonably
likely to remain in the backlog and be converted into revenues.
This includes customer purchase orders and may include amounts
under supply contracts if they meet the aforementioned criteria.
Generally, a higher 12-month backlog is better for us.
Our 12-month backlog at March 31, 2019 was approximately $17.1
million, an increase of 34%, compared to $12.8 million as of June
30, 2018. Backlog growth rates for the last five fiscal quarters
are as follows:
Quarter
|
Backlog ($ 000)
|
Change From Prior Year End
|
Change From Prior Quarter End
|
Q3 2018
|
$12,898
|
38%
|
5%
|
Q4 2018
|
$12,828
|
38%
|
-1%
|
Q1 2019
|
$13,994
|
9%
|
9%
|
Q2 2019
|
$18,145
|
41%
|
30%
|
Q3 2019
|
$17,137
|
34%
|
-6%
|
The increase in our 12-month backlog from the first quarter to the
second quarter of fiscal 2019 was largely due to the renewal of a
large annual contract during the second quarter, which we began
shipping against during the third quarter of fiscal 2019. During
the third quarter of fiscal 2019, we expected orders from customers
based on previous purchase patterns, which did not occur. We
believe these customers simply pushed back the timing of these
orders. Thus, our shipments exceeded bookings, resulting in a 6%
decrease in backlog as compared to the prior quarter end. However,
backlog remains at a significantly higher level than the same
period of the prior fiscal year.
We have experienced strong demand for infrared products used in the
industrial, defense and first responder sectors. Demand for
infrared products is being further fueled by interest in lenses
made with our new BD6 material. We expect to maintain moderate
growth in our visible PMO product group by continuing to diversify
and offer new applications, with a cost competitive structure. Over
the past several years, we have broadened our capabilities to
include additional glass types and the ability to make much larger
lenses, providing long-term opportunities for our technology
roadmap and market share expansion. Based on our backlog and recent
quote activity, we expect increases in revenue from sales of both
molded and turned infrared products for the remainder of fiscal
2019.
27
Revenue Dollars and Units by Product Group
The following table sets forth revenue dollars and units for our
three product groups for the three and nine-month periods ended
March 31, 2019 and 2018:
|
Three months
ended March 31,
|
|
Nine
months ended
March 31,
|
|
||
|
2019
|
2018
|
Quarter %
Change
|
2019
|
2018
|
Year-to-date
% Change
|
Revenue
|
|
|
|
|
|
|
PMO
|
$3,351,916
|
$3,603,670
|
-7%
|
$10,590,111
|
$10,144,516
|
4%
|
Infrared
Products
|
3,833,969
|
4,149,026
|
-8%
|
12,524,741
|
11,987,377
|
4%
|
Specialty
Products
|
719,697
|
750,932
|
-4%
|
1,888,958
|
2,305,201
|
-18%
|
Total
revenue
|
$7,905,582
|
$8,503,628
|
-7%
|
$25,003,810
|
$24,437,094
|
2%
|
|
|
|
|
|
|
|
Units
|
|
|
|
|
|
|
PMO
|
568,484
|
573,320
|
-1%
|
1,646,625
|
1,639,979
|
0%
|
Infrared
Products
|
56,620
|
38,211
|
48%
|
144,653
|
101,140
|
43%
|
Specialty
Products
|
17,310
|
12,684
|
36%
|
52,171
|
58,485
|
-11%
|
Total
units
|
642,414
|
624,215
|
3%
|
1,843,449
|
1,799,604
|
2%
|
Three months ended March 31, 2019
Our revenue decreased approximately $598,000, or 7%, for the third
quarter of fiscal 2019, as compared to the prior year period, due
to similar decreases in all three product groups.
Revenue from the PMO product group for the third quarter of fiscal
2019 was $3.4 million, a decrease of approximately $252,000, or 7%,
as compared to the same period of the prior fiscal year. Sales of
PMO units decreased by 1%, as compared to the prior year period,
however, average selling prices decreased 6%, due to the mix of
products shipped. The decrease in revenue and units sold was
primarily due to a shift in product mix with increases in sales to
customers in the telecommunications and industrial markets, offset
by decreases in our other markets.
Revenue generated by the infrared product group during the third
quarter of fiscal 2019 was $3.8 million, a decrease of $315,000, or
8%, as compared to the same period of the prior fiscal year. During
the third quarter of fiscal 2019, sales of infrared units increased
by 48%, as compared to the prior year period, and average selling
prices decreased by 38%. These changes are driven by an increase in
sales of molded infrared products, which are higher in volume and
lower in price than diamond turned infrared products. Industrial
applications, firefighting cameras and other public safety
applications are the primary drivers of the increased demand for
infrared products.
In the third quarter of fiscal 2019, our specialty products revenue
decreased by $31,000, or 4%, as compared to the same period of the
prior fiscal year. This decrease is primarily due to lower sales to
customers in the defense and medical markets, partially offset by
increases in sales to customers in the industrial market, as well
as an increase in catalog and distribution sales.
Nine months ended March 31, 2019
Our revenue increased approximately $567,000, or 2%, for the first
nine months of fiscal 2019, as compared to the prior year period,
driven by increases in both infrared and PMO, partially offset by a
decrease in specialty product sales.
Revenue from the PMO product group for the first nine months of
fiscal 2019 was approximately $10.6 million, an increase of
approximately $446,000, or 4%, as compared to the same period of
the prior fiscal year. Sales of PMO units were relatively flat, as
compared to the prior year period, and average selling prices
increased 4%, due to the mix of products shipped. The increase in
revenue is primarily due to an increase in sales to customers in
the telecommunications markets, partially offset by decreases in
sales to customers in the medical and commercial markets. For the
first nine months of fiscal 2019, average selling prices of
telecommunications products are higher than in the same period of
the prior fiscal year; however, average selling prices were lower
for the most recent quarter.
Revenue generated by the infrared product group during the first
nine months of fiscal 2019 was approximately $12.5 million, an
increase of $537,000, or 4%, as compared to the same period of the
prior fiscal year. During the first nine months of fiscal 2019,
sales of infrared units increased by 43%, as compared to the prior
year period, and average selling prices decreased by 27%. These
changes are due to the following: (i) a shift in infrared revenue
mix driven by a large-volume order, as compared to the first nine
months of the prior fiscal year, and (ii) an increase in sales of
molded infrared products, which are higher in volume and lower in
price than diamond turned infrared products. Industrial
applications, firefighting cameras and other public safety
applications are the primary drivers of the increased demand for
infrared products.
In the first nine months of fiscal 2019, our specialty products
revenue decreased by $416,000, or 18%, as compared to the same
period of the prior fiscal year. This decrease was primarily
related to revenues generated for NRE projects. NRE revenue is
project based and the timing of any such projects is wholly
dependent on our customers and their project activity. The first
nine months of fiscal 2018 included a large NRE project, which was
not repeated in the first nine months of fiscal 2019. There was
also a decrease in sales of specialty products to customers in the
commercial, industrial and defense markets, partially offset by
increased sales to medical customers.
28
Other Key Indicators
Other key indicators include various operating metrics, some of
which are qualitative and others are quantitative. These indicators
change from time to time as the opportunities and challenges in the
business change. They are mostly non-financial indicators, such as
on-time delivery trends, units of shippable output by major product
line, production yield rates by major product line, and the output
and yield data from significant intermediary manufacturing
processes that support the production of the finished shippable
product. These indicators can be used to calculate such other
related indicators as fully-yielded unit production per-shift,
which varies by the particular product and our state of automation
in production of that product at any given time. Higher unit
production per shift means lower unit cost and, therefore, improved
margins or improved ability to compete, where desirable, for
price-sensitive customer applications. The data from these reports
is used to determine tactical operating actions and changes.
Management also assesses business performance and makes business
decisions regarding our operations using certain non-GAAP measures.
These non-GAAP measures are described in more detail below under
the heading “Non-GAAP Financial Measures.”
Non-GAAP Financial Measures
We report our historical results in accordance with GAAP; however,
our management also assesses business performance and makes
business decisions regarding our operations using certain non-GAAP
measures. We believe these non-GAAP financial measures provide
useful information to management and investors that is
supplementary to our financial condition and results of operations
computed in accordance with GAAP; however, we acknowledge that our
non-GAAP financial measures have a number of limitations. As such,
you should not view these disclosures as a substitute for results
determined in accordance with GAAP, and they are not necessarily
comparable to non-GAAP measures that other companies
use.
Adjusted Net Income
Adjusted net income is a non-GAAP financial measure used by
management, lenders, and certain investors, as a supplemental
measure in the evaluation of some aspects of a corporation’s
financial position and core operation performance. Management uses
adjusted net income to evaluate our underlying operating
performance. We believe adjusted net income may be helpful for
investors as one means of evaluating our operational
performance.
We calculate adjusted net income by excluding the change in the
fair value of the warrants issued in connection with our private
placement in June 2012 from net income. The fair value of the June
2012 warrants was re-measured each reporting period until the
warrants were exercised or expired (which expiration occurred on
December 11, 2017). In each reporting period during the term of
June 2012 warrants, the change in the fair value of the June 2012
warrants was either recognized as non-cash expense or non-cash
income. The change in the fair value of the June 2012 warrants was
not impacted by our actual operations but was instead strongly tied
to the change in the market value of our Class A common stock. The
following table reconciles adjusted net income to net income for
the three and nine months ended March 31, 2019 and
2018:
|
(unaudited)
|
|||
|
Quarter
Ended:
|
Nine
Months Ended:
|
||
|
March
31,
2019
|
March
31,
2018
|
March
31,
2019
|
March
31,
2018
|
Net
income (loss)
|
$(352,018)
|
$1,226,279
|
$(918,633)
|
$1,867,324
|
Change
in fair value of warrant liability
|
—
|
—
|
—
|
194,632
|
Adjusted
net income (loss)
|
$(352,018)
|
$1,226,279
|
$(918,633)
|
$2,061,956
|
%
of revenue
|
-4%
|
14%
|
-4%
|
8%
|
29
Our adjusted net loss for the third quarter of fiscal 2019 was
approximately $352,000, as compared to adjusted net income of
approximately $1.2 million for the same period of the prior fiscal
year. The decrease in adjusted net income in the third quarter of
fiscal 2019, is attributable to the following, which are primarily
non-operating items: (i) decrease in operating income of $195,000,
due to additional expenses related to the relocation of the
Irvington Facility and an increase in new product development
costs, (ii) an unfavorable difference in interest expense of
$618,000, due to the refinancing transactions described above,
(iii) a decrease in foreign exchange gains of approximately
$400,000, and (iv) a $345,000 decrease in the income tax
benefit.
Our adjusted net loss for the first nine months of fiscal 2019 was
approximately $919,000, as compared to adjusted net income of
approximately $2.1 million for the same period of the prior fiscal
year. The decrease in adjusted net income in the first nine months
of fiscal 2019 was caused by the following: (i) a decrease in gross
margin of approximately $403,000, (ii) an increase in SG&A
costs, including $394,000 in additional expenses related to the
relocation of the Irvington Facility, (iii) an increase in new
product development costs of approximately $316,000, (iv) an
increase in interest expense of $521,000, due to the refinancing
transactions described above, (v) an approximately $1.2 million
unfavorable difference in foreign exchange gains and losses, and
(vi) a decrease in income tax benefits of $278,000.
EBITDA and Adjusted EBITDA
EBITDA and adjusted EBITDA are non-GAAP financial measures used by
management, lenders, and certain investors as a supplemental
measure in the evaluation of some aspects of a corporations’
financial position and core operating performance. Investors
sometimes use EBITDA, as it allows for some level of comparability
of profitability trends between those businesses differing as to
capital structure and capital intensity by removing the impacts of
depreciation and amortization. EBITDA also does not include changes
in major working capital items, such as receivables, inventory and
payables, which can also indicate a significant need for, or source
of, cash. Since decisions regarding capital investment and
financing and changes in working capital components can have a
significant impact on cash flow, EBITDA is not necessarily a good
indicator of a business' cash flows. We use EBITDA for evaluating
the relative underlying performance of our core operations and for
planning purposes. We calculate EBITDA by adjusting net income to
exclude net interest expense, income tax expense or benefit,
depreciation and amortization, thus the term “Earnings Before
Interest, Taxes, Depreciation and Amortization” and the
acronym “EBITDA.”
We also calculate an adjusted EBITDA, which excludes the effect of
the non-cash income or expense associated with the mark-to-market
adjustments, related to our June 2012 warrants. The fair value of
the June 2012 warrants was re-measured each reporting period until
the warrants were either exercised or expired (which expiration
occurred on December 11, 2017). Each reporting period, the change
in the fair value of the June 2012 warrants was either recognized
as a non-cash expense or non-cash income. The change in the fair
value of the June 2012 warrants was not impacted by our actual
operations but was instead strongly tied to the change in the
market value of our Class A common stock. Management uses adjusted
EBITDA to evaluate our underlying operating performance and for
planning and forecasting future business operations. We believe
this adjusted EBITDA is helpful for investors to better understand
our underlying business operations. The following table reconciles
EBITDA and adjusted EBITDA to net income for the three and nine
months ended March 31, 2019 and 2018:
|
(unaudited)
|
|||
|
Quarter
Ended:
|
Nine
Months Ended:
|
||
|
March
31,
2019
|
March
31,
2018
|
March
31,
2019
|
March
31,
2018
|
Net
income (loss)
|
$(352,018)
|
$1,226,279
|
$(918,633)
|
$1,867,324
|
Depreciation
and amortization
|
857,287
|
866,329
|
2,540,963
|
2,492,003
|
Income
tax provision (benefit)
|
161,870
|
(183,154)
|
(40,493)
|
(318,678)
|
Interest
expense
|
275,233
|
(342,796)
|
573,535
|
52,212
|
EBITDA
|
942,372
|
1,566,658
|
$2,155,372
|
$4,092,861
|
Change
in fair value of warrant liability
|
—
|
—
|
—
|
194,632
|
Adjusted
EBITDA
|
$942,372
|
$1,566,658
|
$2,155,372
|
$4,287,493
|
%
of revenue
|
12%
|
18%
|
9%
|
18%
|
30
Our adjusted EBITDA for the third quarter of fiscal 2019 was
approximately $942,000, compared to approximately $1.6 million for
the same period of the prior fiscal year. The decrease in adjusted EBITDA in the third
quarter of fiscal 2019 was caused by lower sales resulting in lower
gross margin, coupled with additional expenses related to the
relocation of the Irvington Facility and an increase in new product
development costs, as well as a decrease in foreign exchange gains
of approximately $380,000.
Our adjusted EBITDA for the first nine months of fiscal 2019 was
approximately $2.2 million, compared to approximately $4.3 million
for the same period of the prior fiscal year. The decrease in adjusted EBITDA in the first nine
months of fiscal 2019 was caused by the decrease in gross margin,
additional SG&A expenses related to the relocation of the
Irvington Facility, an increase in new product development costs,
and an approximately $1.2 million unfavorable difference in foreign
exchange gains and losses.
Item 4. Controls and
Procedures
Under
the supervision and with the participation of our management,
including our Chief Executive Officer and our Chief Financial
Officer, we evaluated the effectiveness of the design and operation
of our disclosure controls and procedures (as defined in Rule
13a-15(e) under the Exchange Act) as of March 31, 2019, the end of
the period covered by this report. Based on that evaluation, the
Chief Executive Officer and Chief Financial Officer concluded that
our disclosure controls and procedures were effective as of March
31, 2019 in reporting on a timely basis information required to be
disclosed by us in the reports we file or submit under the Exchange
Act.
During the fiscal quarter ended March 31, 2019, there was no change
in our internal control over financial reporting (as defined in
Rule 13a-15(f) under the Exchange Act) that has materially
affected, or is reasonably likely to materially affect, our
internal control over financial reporting.
31
PART II OTHER INFORMATION
Item 1. Legal Proceedings
None
Item 2. Unregistered Sales of Equity
Securities and Use of Proceeds
None
Item 3. Defaults Upon Senior
Securities
None
Item 4. Mine Safety
Disclosures
None
Item 5. Other Information
Entry
Into a Material Definitive Agreement
Creation of a
Direct Financial Obligation or an Obligation Under an Off-Balance
Sheet Arrangement of Registrant
On May 6, 2019, and effective as of February 26, 2019, we entered
into the Amendment, which amends the Loan Agreement entered into
with BankUnited. The Amendment amends the definition of the fixed
charge coverage ratio to more accurately reflect the understandings
of BankUnited and us at the time the Loan Agreement was executed.
The revised definition of “fixed charge coverage ratio”
allows BankUnited to approve of certain non-cash expenses in
calculating the ratio. The revised definition also allows for the
initial four (4) testing periods, beginning on March 31, 2019, to
use the twelve (12) month pro forma scheduled principal and
interest payments to BankUnited, instead of payments previously
paid to AvidBank, in addition to all capital lease payments. After
the initial four (4) testing periods, the calculation will revert
to actual scheduled principal and interest payments to BankUnited,
as well as all capital lease payments.
The foregoing descriptions of the Amendment are summaries only and
are qualified in their entirety by reference to the complete text
of the Amendment filed herewith as Exhibit 10.10.
Item 6. Exhibits
The following exhibits are filed herewith as a part of this
report.
32
Exhibit Number
|
|
Description
|
||
|
|
|
||
3.1.1
|
|
Certificate of Incorporation of LightPath Technologies, Inc., filed
June 15, 1992 with the Secretary of State of Delaware, which was
filed as an exhibit to our Registration Statement on Form SB-2
(File No: 33-80119) filed with the Securities and Exchange
Commission on December 7, 1995, and is incorporated herein by
reference thereto.
|
||
|
|
|
||
3.1.2
|
|
Certificate of Amendment to Certificate of Incorporation of
LightPath Technologies, Inc., filed October 2, 1995 with the
Secretary of State of Delaware, which was filed as an exhibit to
our Registration Statement on Form SB-2 (File No: 33-80119) filed
with the Securities and Exchange Commission on December 7, 1995,
and is incorporated herein by reference thereto.
|
||
|
|
|
||
3.1.3
|
|
Certificate of Designations of Class A common stock and Class E-1
common stock, Class E-2 common stock, and Class E-3 common stock of
LightPath Technologies, Inc., filed November 9, 1995 with the
Secretary of State of Delaware, which was filed as an exhibit to
our Registration Statement on Form SB-2 (File No: 33-80119) filed
with the Securities and Exchange Commission on December 7, 1995,
and is incorporated herein by reference thereto.
|
||
|
|
|
||
|
Certificate of Designation of Series A Preferred Stock of LightPath
Technologies, Inc., filed July 9, 1997 with the Secretary of State
of Delaware, which was filed as Exhibit 3.4 to our Annual Report on
Form 10-KSB40 filed with the Securities and Exchange Commission on
September 11, 1997, and is incorporated herein by reference
thereto.
|
|||
|
|
|
||
|
Certificate of Designation of Series B Stock of LightPath
Technologies, Inc., filed October 2, 1997 with the Secretary of
State of Delaware, which was filed as Exhibit 3.2 to our Quarterly
Report on Form 10-QSB (File No. 000-27548) filed with the
Securities and Exchange Commission on November 14, 1997, and is
incorporated herein by reference thereto.
|
|||
|
|
|
||
|
Certificate of Amendment of Certificate of Incorporation of
LightPath Technologies, Inc., filed November 12, 1997 with the
Secretary of State of Delaware, which was filed as Exhibit 3.1 to
our Quarterly Report on Form 10-QSB (File No. 000-27548) filed with
the Securities and Exchange Commission on November 14, 1997, and is
incorporated herein by reference thereto.
|
|||
|
|
|||
|
Certificate of Designation of Series C Preferred Stock of LightPath
Technologies, Inc., filed February 6, 1998 with the Secretary of
State of Delaware, which was filed as Exhibit 3.2 to our
Registration Statement on Form S-3 (File No. 333-47905) filed with
the Securities and Exchange Commission on March 13, 1998, and is
incorporated herein by reference thereto.
|
|||
|
|
|
||
|
Certificate of Designation, Preferences and Rights of Series D
Participating Preferred Stock of LightPath Technologies, Inc. filed
April 29, 1998 with the Secretary of State of Delaware, which was
filed as Exhibit 1 to our Registration Statement on Form 8-A (File
No. 000-27548) filed with the Securities and Exchange Commission on
April 28, 1998, and is incorporated herein by reference
thereto.
|
33
Certificate of Designation of Series F Preferred Stock of LightPath
Technologies, Inc., filed November 2, 1999 with the Secretary of
State of Delaware, which was filed as Exhibit 3.2 to our
Registration Statement on Form S-3 (File No: 333-94303) filed with
the Securities and Exchange Commission on January 10, 2000, and is
incorporated herein by reference thereto.
|
|||||
|
|
||||
|
Certificate of Amendment of Certificate of Incorporation of
LightPath Technologies, Inc., filed February 28, 2003 with the
Secretary of State of Delaware, which was filed as Appendix A to
our Proxy Statement (File No. 000-27548) filed with the Securities
and Exchange Commission on January 24, 2003, and is incorporated
herein by reference thereto.
|
||||
|
|||||
Certificate of Amendment of Certificate of Incorporation of
LightPath Technologies, Inc., filed March 1, 2016 with the
Secretary of State of Delaware, which was filed as Exhibit 3.1.11
to our Quarterly Report on Form 10-Q (File No: 000-27548) filed
with the Securities and Exchange Commission on November 14, 2016,
and is incorporated herein by reference thereto.
|
|||||
|
|||||
Certificate of Amendment of Certificate of Incorporation of
LightPath Technologies, Inc., filed October 30, 2017 with the
Secretary of State of Delaware, which was filed as Exhibit 3.1 to
our Current Report on Form 8-K (File No: 000-27548) filed with the
Securities and Exchange Commission on October 31, 2017, and is
incorporated herein by reference thereto.
|
|||||
|
|||||
Certificate of Amendment of Certificate of Designations of Class A
Common Stock and Class E-1 Common Stock, Class E-2 Common Stock,
and Class E-3 Common Stock of LightPath Technologies, Inc., filed
October 30, 2017 with the Secretary of State of Delaware, which was
filed as Exhibit 3.2 to our Current Report on Form 8-K (File No:
000-27548) filed with the Securities and Exchange Commission on
October 31, 2017, and is incorporated herein by reference
thereto.
|
|||||
|
|||||
Certificate of Amendment of Certificate of Designation, Preferences
and Rights of Series D Participating Preferred Stock of LightPath
Technologies, Inc., filed January 30, 2018 with the Secretary of
State of Delaware, which was filed as Exhibit 3.1 to our Current
Report on Form 8-K (File No: 000-27548) filed with the Securities
and Exchange Commission on February 1, 2018, and is incorporated
herein by references thereto.
|
|||||
|
|
||||
Amended and Restated Bylaws of LightPath Technologies, Inc., which
was filed as Exhibit 3.1 to our Current Report on Form 8-K (File
No: 000-27548) filed with the Securities and Exchange Commission on
February 3, 2015, and is incorporated herein by reference
thereto.
|
|||||
|
|||||
First Amendment to Amended and Restated Bylaws of LightPath
Technologies, Inc., which was filed as Exhibit 3.1 to our Current
Report on Form 8-K (File No: 000-27548) filed with the Securities
and Exchange Commission on September 21, 2017, and is incorporated
herein by reference thereto.
|
34
10.1
|
First Amendment to Lease, dated January 9, 2019, by and between
LightPath Technologies, Inc. and CIO University Tech,
LLC*
|
|||
|
|
|||
Loan Agreement dated February 26, 2019 by and between LightPath
Technologies, Inc. and BankUnited, N.A., which was filed as Exhibit
10.1 to our Current Report on Form 8-K (File No: 000-27548) filed
with the Securities and Exchange Commission on March 1, 2019, and
is incorporated herein by reference thereto.
|
||||
|
||||
Term Loan Note dated February 26, 2019 by LightPath Technologies,
Inc. in favor of BankUnited, N.A., which was filed as Exhibit 10.2
to our Current Report on Form 8-K (File No: 000-27548) filed with
the Securities and Exchange Commission on March 1, 2019, and is
incorporated herein by reference thereto.
|
||||
|
||||
Revolving Credit Note dated February 26, 2019 by LightPath
Technologies, Inc. in favor of BankUnited, N.A., which was filed as
Exhibit 10.3 to our Current Report on Form 8-K (File No: 000-27548)
filed with the Securities and Exchange Commission on March 1, 2019,
and is incorporated herein by reference thereto.
|
||||
|
||||
Guidance Line Note dated February 26, 2019 by LightPath
Technologies, Inc. in favor of BankUnited, N.A., which was filed as
Exhibit 10.4 to our Current Report on Form 8-K (File No: 000-27548)
filed with the Securities and Exchange Commission on March 21,
2019, and is incorporated herein by reference thereto.
|
||||
|
||||
Security Agreement dated February 26, 2019 by LightPath
Technologies, Inc. in favor of BankUnited, N.A., and joined by
GelTech, Inc. and ISP Optics Corporation, which was filed as
Exhibit 10.5 to our Current Report on Form 8-K (File No: 000-27548)
filed with the Securities and Exchange Commission on March 1, 2019,
and is incorporated herein by reference thereto.
|
||||
|
||||
Guaranty Agreement (Term Loan) dated February 26, 2019 by GelTech
Inc., ISP Optics Corporation, LightPath Optical Instrumentation
(Shanghai) Co., Ltd., LightPath Optical Instrumentation (Zhenjiang)
Co., Ltd., and ISP Optics Latvia, SIA in favor of BankUnited, N.A.,
which was filed as Exhibit 10.6 to our Current Report on Form 8-K
(File No: 000-27548) filed with the Securities and Exchange
Commission on March 1, 2019, and is incorporated herein by
reference thereto.
|
||||
|
||||
Guaranty Agreement (Revolving Credit) dated February 26, 2019 by
GelTech Inc., ISP Optics Corporation, LightPath Optical
Instrumentation (Shanghai) Co., Ltd., LightPath Optical
Instrumentation (Zhenjiang) Co., Ltd., and ISP Optics Latvia, SIA
in favor of BankUnited, N.A., which was filed as Exhibit 10.7 to
our Current Report on Form 8-K (File No: 000-27548) filed with the
Securities and Exchange Commission on March 1, 2019, and is
incorporated herein by reference thereto.
|
||||
|
||||
Guaranty Agreement (Guidance Line) dated February 26, 2019 by
GelTech Inc., ISP Optics Corporation, LightPath Optical
Instrumentation (Shanghai) Co., Ltd., LightPath Optical
Instrumentation (Zhenjiang) Co., Ltd., and ISP Optics Latvia, SIA
in favor of BankUnited, N.A., which was filed as Exhibit 10.8 to
our Current Report on Form 8-K (File No: 000-27548) filed with the
Securities and Exchange Commission on March 1, 2019, and is
incorporated herein by reference thereto.
|
||||
|
|
|||
First
Amendment to Loan Agreement dated May 6, 2019, and effective
February 26, 2019, by and between LightPath Technologies, Inc. and
BankUnited, N.A.*
|
||||
|
|
|||
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)
of the Securities Exchange Act of 1934*
|
||||
|
|
|||
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)
of the Securities Exchange Act of 1934*
|
||||
|
||||
Certification of Chief Executive Officer pursuant to 18 U.S.C.
Section 1350 of Chapter 63 of Title 18 of the United States
Code*
|
||||
|
|
|||
Certification of Chief Financial Officer pursuant to 18 U.S.C.
Section 1350 of Chapter 63 of Title 18 of the United States
Code*
|
101.INS
XBRL Instance Document*
101.SCH
XBRL Taxonomy Extension Schema
Document*
101.CAL
XBRL Taxonomy Extension Calculation Linkbase
Document*
101.DEF
XBRL Taxonomy
Extension Definition Linkbase Document*
101.LAB
XBRL Taxonomy Extension Label Linkbase
Document*
101.PRE
XBRL Taxonomy Presentation Linkbase
Document*
*filed herewith
35
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly
authorized.
|
LIGHTPATH TECHNOLOGIES, INC. |
|
|
|
|
|
|
Date: May 9, 2019
|
By:
|
/s/ J. James
Gaynor
|
|
|
|
J. James
Gaynor
|
|
|
|
President
and Chief Executive Officer
|
|
Date: May 9, 2019
|
By:
|
/s/ Donald O.
Retreage, Jr.
|
|
|
|
Donald O. Retreage,
Jr.
|
|
|
|
Chief
Financial Officer
|
|